BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-692. [PMID: 17320506 DOI: 10.1016/j.cell.2007.01.029] [Cited by in Crossref: 3033] [Cited by in F6Publishing: 2820] [Article Influence: 202.2] [Reference Citation Analysis]
Number Citing Articles
1 Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546-1558. [PMID: 23539594 DOI: 10.1126/science.1235122] [Cited by in Crossref: 4552] [Cited by in F6Publishing: 3999] [Article Influence: 505.8] [Reference Citation Analysis]
2 Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Lymphoma 2012;53:123-9. [PMID: 21806350 DOI: 10.3109/10428194.2011.597905] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
3 Baur B, Bozdag S. A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data. PLoS One 2016;11:e0148977. [PMID: 26872146 DOI: 10.1371/journal.pone.0148977] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
4 Loeb LA, Monnat RJ. DNA polymerases and human disease. Nat Rev Genet 2008;9:594-604. [DOI: 10.1038/nrg2345] [Cited by in Crossref: 197] [Cited by in F6Publishing: 175] [Article Influence: 14.1] [Reference Citation Analysis]
5 Kaneda A, Yagi K. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes. Cancer Sci. 2011;102:18-24. [PMID: 21159060 DOI: 10.1111/j.1349-7006.2010.01712.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
6 Reimand J, Wagih O, Bader GD. The mutational landscape of phosphorylation signaling in cancer. Sci Rep 2013;3:2651. [PMID: 24089029 DOI: 10.1038/srep02651] [Cited by in Crossref: 113] [Cited by in F6Publishing: 93] [Article Influence: 12.6] [Reference Citation Analysis]
7 Stavrovskaya AA, Shushanov SS, Rybalkina EY. Problems of Glioblastoma Multiforme Drug Resistance. Biochemistry (Mosc) 2016;81:91-100. [PMID: 27260389 DOI: 10.1134/S0006297916020036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 20] [Article Influence: 9.4] [Reference Citation Analysis]
8 Minatani N, Waraya M, Yamashita K, Kikuchi M, Ushiku H, Kojo K, Ema A, Nishimiya H, Kosaka Y, Katoh H, Sengoku N, Tanino H, Sidransky D, Watanabe M. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. PLoS One 2016;11:e0144862. [PMID: 26785325 DOI: 10.1371/journal.pone.0144862] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
9 Recillas-Targa F, de la Rosa-Velázquez IA, Soto-Reyes E. Insulation of tumor suppressor genes by the nuclear factor CTCF. Biochem Cell Biol 2011;89:479-88. [PMID: 21846316 DOI: 10.1139/o11-031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Rengucci C, De Maio G, Casadei Gardini A, Zucca M, Scarpi E, Zingaretti C, Foschi G, Tumedei MM, Molinari C, Saragoni L, Puccetti M, Amadori D, Zoli W, Calistri D. Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. J Exp Clin Cancer Res 2014;33:65. [PMID: 25091577 DOI: 10.1186/s13046-014-0065-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
11 Andreu-Vieyra CV, Liang G. Nucleosome occupancy and gene regulation during tumorigenesis. Adv Exp Med Biol 2013;754:109-34. [PMID: 22956498 DOI: 10.1007/978-1-4419-9967-2_5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
12 Javid M, Sasanakietkul T, Nicolson NG, Gibson CE, Callender GG, Korah R, Carling T. DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers. World J Surg 2018;42:358-66. [PMID: 29075860 DOI: 10.1007/s00268-017-4299-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Patino WD, Susa J. Epigenetics of cutaneous melanoma. Adv Dermatol 2008;24:59-70. [PMID: 19256305 DOI: 10.1016/j.yadr.2008.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
14 Takahashi Y, Nakamura H, Makino K, Hide T, Muta D, Kamada H, Kuratsu J. Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients. World J Surg Oncol 2013;11:284. [PMID: 24160898 DOI: 10.1186/1477-7819-11-284] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
15 Papoutsis AJ, Borg JL, Selmin OI, Romagnolo DF. BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. J Nutr Biochem 2012;23:1324-32. [PMID: 22197621 DOI: 10.1016/j.jnutbio.2011.08.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
16 Fang F, Zuo Q, Pilrose J, Wang Y, Shen C, Li M, Wulfridge P, Matei D, Nephew KP. Decitabine reactivated pathways in platinum resistant ovarian cancer. Oncotarget 2014;5:3579-89. [PMID: 25003579 DOI: 10.18632/oncotarget.1961] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
17 Starlard-Davenport A, Tryndyak VP, James SR, Karpf AR, Latendresse JR, Beland FA, Pogribny IP. Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats. Carcinogenesis 2010;31:376-81. [PMID: 20008439 DOI: 10.1093/carcin/bgp304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
18 Ferreira HJ, Heyn H, Moutinho C, Esteller M. CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer. RNA Biol 2012;9:881-90. [PMID: 22617881 DOI: 10.4161/rna.19353] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
19 Erdmann A, Arimondo PB, Guianvarc’h D. Structure-Guided Optimization of DNA Methyltransferase Inhibitors. Epi-Informatics. Elsevier; 2016. pp. 53-73. [DOI: 10.1016/b978-0-12-802808-7.00003-4] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knüchel R, Dahl E. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer. 2008;8:154. [PMID: 18513385 DOI: 10.1186/1471-2407-8-154] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
21 Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008;9:465-476. [PMID: 18463664 DOI: 10.1038/nrg2341] [Cited by in Crossref: 1929] [Cited by in F6Publishing: 1753] [Article Influence: 137.8] [Reference Citation Analysis]
22 Navada SC, Steinmann J, Lübbert M, Silverman LR. Clinical development of demethylating agents in hematology. J Clin Invest 2014;124:40-6. [PMID: 24382388 DOI: 10.1172/JCI69739] [Cited by in Crossref: 97] [Cited by in F6Publishing: 53] [Article Influence: 12.1] [Reference Citation Analysis]
23 Maegley KA, Krivacic C, Bingham P, Liu W, Brooun A. Comparison of a High-Throughput Mass Spectrometry Method and Radioactive Filter Binding to Assay the Protein Methyltransferase PRMT5. Assay Drug Dev Technol 2015;13:235-40. [PMID: 26065559 DOI: 10.1089/adt.2015.640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
24 Satapathy S, Batra J, Jeet V, Thompson EW, Punyadeera C. MicroRNAs in HPV associated cancers: small players with big consequences. Expert Rev Mol Diagn 2017;17:711-22. [PMID: 28597695 DOI: 10.1080/14737159.2017.1339603] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
25 Liu R, Zhang XH, Zhang K, Li W, Wang WJ, Luo DX, Gao L. 5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene. Int J Ophthalmol 2014;7:51-6. [PMID: 24634863 DOI: 10.3980/j.issn.2222-3959.2014.01.09] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
26 Muthusamy V, Bosenberg M, Wajapeyee N. Redefining regulation of DNA methylation by RNA interference. Genomics 2010;96:191-8. [PMID: 20620207 DOI: 10.1016/j.ygeno.2010.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
27 Bullinger L, Armstrong SA. HELP for AML: methylation profiling opens new avenues. Cancer Cell 2010;17:1-3. [PMID: 20129241 DOI: 10.1016/j.ccr.2009.12.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
28 Foreman KW, Brown M, Park F, Emtage S, Harriss J, Das C, Zhu L, Crew A, Arnold L, Shaaban S, Tucker P. Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS One 2011;6:e22290. [PMID: 21779408 DOI: 10.1371/journal.pone.0022290] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
29 Jiao X, Zhang S, Jiao J, Zhang T, Qu W, Muloye GM, Kong B, Zhang Q, Cui B. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clin Epigenetics 2019;11:120. [PMID: 31426855 DOI: 10.1186/s13148-019-0719-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
30 Weisenberger DJ. Characterizing DNA methylation alterations from The Cancer Genome Atlas. J Clin Invest 2014;124:17-23. [PMID: 24382385 DOI: 10.1172/JCI69740] [Cited by in Crossref: 114] [Cited by in F6Publishing: 76] [Article Influence: 14.3] [Reference Citation Analysis]
31 Pogribny IP, Kobets T, Beland FA. Alterations in DNA Methylation Resulting from Exposure to Chemical Carcinogens. In: John Wiley & Sons Ltd, editor. eLS. Chichester: John Wiley & Sons, Ltd; 2001. [DOI: 10.1002/9780470015902.a0025456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007;25:801-12. [PMID: 17363312 DOI: 10.1016/j.molcel.2007.03.001] [Cited by in Crossref: 337] [Cited by in F6Publishing: 322] [Article Influence: 22.5] [Reference Citation Analysis]
33 Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene. 2007;26:5489-5504. [PMID: 17694089 DOI: 10.1038/sj.onc.1210616] [Cited by in Crossref: 422] [Cited by in F6Publishing: 424] [Article Influence: 28.1] [Reference Citation Analysis]
34 Wang Y, Zhang Y, Guo Y, Kang XF. Fast and precise detection of DNA methylation with tetramethylammonium-filled nanopore. Sci Rep 2017;7:183. [PMID: 28298646 DOI: 10.1038/s41598-017-00317-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
35 Anelli V, Santoriello C, Distel M, Köster RW, Ciccarelli FD, Mione M. Global Repression of Cancer Gene Expression in a Zebrafish Model of Melanoma Is Linked to Epigenetic Regulation. Zebrafish 2009;6:417-24. [DOI: 10.1089/zeb.2009.0612] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
36 Shinjo K, Hara K, Nagae G, Umeda T, Katsushima K, Suzuki M, Murofushi Y, Umezu Y, Takeuchi I, Takahashi S, Okuno Y, Matsuo K, Ito H, Tajima S, Aburatani H, Yamao K, Kondo Y. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer. PLoS One 2020;15:e0233782. [PMID: 32520974 DOI: 10.1371/journal.pone.0233782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Karagiannis TC, Maulik N. Factors influencing epigenetic mechanisms and related diseases. Antioxid Redox Signal 2012;17:192-4. [PMID: 22339352 DOI: 10.1089/ars.2012.4562] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
38 Tastanova A, Schulz A, Folcher M, Tolstrup A, Puklowski A, Kaufmann H, Fussenegger M. Overexpression of YY1 increases the protein production in mammalian cells. Journal of Biotechnology 2016;219:72-85. [DOI: 10.1016/j.jbiotec.2015.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
39 Lewis ZA, Adhvaryu KK, Honda S, Shiver AL, Selker EU. Identification of DIM-7, a protein required to target the DIM-5 H3 methyltransferase to chromatin. Proc Natl Acad Sci U S A 2010;107:8310-5. [PMID: 20404183 DOI: 10.1073/pnas.1000328107] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
40 Sharma P, Bhunia S, Poojary SS, Tekcham DS, Barbhuiya MA, Gupta S, Shrivastav BR, Tiwari PK. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. Tumor Biol 2016;37:14687-99. [DOI: 10.1007/s13277-016-5355-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
41 Kong EY, Cheng SH, Yu KN. Zebrafish as an In Vivo Model to Assess Epigenetic Effects of Ionizing Radiation. Int J Mol Sci 2016;17:E2108. [PMID: 27983682 DOI: 10.3390/ijms17122108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
42 Sant KE, Nahar MS, Dolinoy DC. DNA methylation screening and analysis. Methods Mol Biol 2012;889:385-406. [PMID: 22669678 DOI: 10.1007/978-1-61779-867-2_24] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
43 Mund C, Lyko F. Epigenetic cancer therapy: Proof of concept and remaining challenges. Bioessays 2010;32:949-57. [PMID: 21154865 DOI: 10.1002/bies.201000061] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
44 Eslami M, Sadrifar S, Karbalaei M, Keikha M, Kobyliak NM, Yousefi B. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells. J Gastrointest Cancer 2020;51:738-47. [PMID: 31735976 DOI: 10.1007/s12029-019-00329-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
45 Shen S, Lin Y, Yuan X, Shen L, Chen J, Chen L, Qin L, Shen B. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Sci Rep. 2016;6:38311. [PMID: 27917899 DOI: 10.1038/srep38311] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
46 Park JW, Turcan Ş. Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas. Cancers (Basel) 2019;11:E1616. [PMID: 31652645 DOI: 10.3390/cancers11101616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
47 Cropley JE, Martin DI, Suter CM. Germline epimutation in humans. Pharmacogenomics 2008;9:1861-8. [PMID: 19072644 DOI: 10.2217/14622416.9.12.1861] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
48 Herceg Z, Ushijima T. Introduction. Epigenetics and Cancer, Part A. Elsevier; 2010. pp. 1-23. [DOI: 10.1016/b978-0-12-380866-0.60001-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
49 Gerard CL, Delyon J, Wicky A, Homicsko K, Cuendet MA, Michielin O. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat Rev 2021;101:102227. [PMID: 34656019 DOI: 10.1016/j.ctrv.2021.102227] [Reference Citation Analysis]
50 Shi C, Xie LY, Tang YP, Long L, Li JL, Hu BL, Li KZ. Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma. Front Genet 2019;10:1097. [PMID: 31781164 DOI: 10.3389/fgene.2019.01097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Peña-Llopis S, Wan Y, Martinez ED. Unique epigenetic gene profiles define human breast cancers with poor prognosis. Oncotarget 2016;7:85819-31. [PMID: 27863398 DOI: 10.18632/oncotarget.13334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
52 Tellez CS, Picchi MA, Juri D, Do K, Desai DH, Amin SG, Hutt JA, Filipczak PT, Belinsky SA. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention. Clin Epigenetics 2021;13:44. [PMID: 33632299 DOI: 10.1186/s13148-021-01034-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol. 2010;2010:369549. [PMID: 20300586 DOI: 10.1155/2010/369549] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
54 Kalinkova L, Zmetakova I, Smolkova B, Minarik G, Sedlackova T, Horvathova Kajabova V, Cierna Z, Mego M, Fridrichova I. Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers. BMC Cancer 2018;18:875. [PMID: 30189837 DOI: 10.1186/s12885-018-4783-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
55 Li LL, Shu XS, Wang ZH, Cao Y, Tao Q. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chin J Cancer 2011;30:231-9. [PMID: 21439244 DOI: 10.5732/cjc.011.10080] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
56 Prabhakar NR, Peng YJ, Kumar GK, Nanduri J. Peripheral chemoreception and arterial pressure responses to intermittent hypoxia. Compr Physiol. 2015;5:561-577. [PMID: 25880505 DOI: 10.1002/cphy.c140039] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
57 Cantariño N, Douet J, Buschbeck M. MacroH2A – An epigenetic regulator of cancer. Cancer Letters 2013;336:247-52. [DOI: 10.1016/j.canlet.2013.03.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
58 Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part I: Covalent histone modifications. Trends Mol Med. 2007;13:363-372. [PMID: 17822958 DOI: 10.1016/j.molmed.2007.07.003] [Cited by in Crossref: 281] [Cited by in F6Publishing: 234] [Article Influence: 18.7] [Reference Citation Analysis]
59 Patra SK, Patra A, Rizzi F, Ghosh TC, Bettuzzi S. Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev 2008;27:315-34. [DOI: 10.1007/s10555-008-9118-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
60 Kang W, Wang Q, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T, Jin X, Cui Z. Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis. Cell Death Dis 2020;11:1038. [PMID: 33288752 DOI: 10.1038/s41419-020-03240-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Jiao W, Xun X, Liu J, Yang J, Wang Q, Wang L, Chen C, Wang H, Dai P. Diagnostic significance of suppressor of cytokine signalling 3 ( SOCS3 ) methylation and its correlation with IDH1 mutation in Chinese glioma patients. Biomarkers 2016;21:686-91. [DOI: 10.3109/1354750x.2016.1139001] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Kim YH, Kakar S, Cun L, Deng G, Kim YS. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer. 2008;123:2587-2593. [PMID: 18798261 DOI: 10.1002/ijc.23840] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
63 Colleti C, Melo-Hanchuk TD, da Silva FRM, Saito Â, Kobarg J. Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions. World J Biol Chem 2019; 10(3): 44-64 [PMID: 31768228 DOI: 10.4331/wjbc.v10.i3.44] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Baylin SB, Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol 2016;8:a019505. [PMID: 27194046 DOI: 10.1101/cshperspect.a019505] [Cited by in Crossref: 371] [Cited by in F6Publishing: 318] [Article Influence: 61.8] [Reference Citation Analysis]
65 Wu YS, Lee ZY, Chuah L, Mai CW, Ngai SC. Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics. CCDT 2019;19:82-100. [DOI: 10.2174/1568009618666180430130248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
66 Ricca TI, Liang G, Suenaga AP, Han SW, Jones PA, Jasiulionis MG. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol 2009;2:329-40. [PMID: 19956395 DOI: 10.1593/tlo.09220] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
67 Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA. Current Diagnosis and Management of Small-Cell Lung Cancer. Mayo Clinic Proceedings 2019;94:1599-622. [DOI: 10.1016/j.mayocp.2019.01.034] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 14.7] [Reference Citation Analysis]
68 Roy B, Tang C, Alam MP, Hecht SM. DNA methylation reduces binding and cleavage by bleomycin. Biochemistry 2014;53:6103-12. [PMID: 25187079 DOI: 10.1021/bi5010848] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kondo N, Tohnai G, Sahashi K, Iida M, Kataoka M, Nakatsuji H, Tsutsumi Y, Hashizume A, Adachi H, Koike H, Shinjo K, Kondo Y, Sobue G, Katsuno M. DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5. EMBO Mol Med 2019;11:e8547. [PMID: 30940675 DOI: 10.15252/emmm.201708547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
70 Du T, Liu B, Wang Z, Wan X, Wu Y. CpG methylation signature predicts prognosis in breast cancer. Breast Cancer Res Treat 2019;178:565-72. [DOI: 10.1007/s10549-019-05417-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 Barthel FP, Johnson KC, Wesseling P, Verhaak RGW. Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 2018;36:421-37. [PMID: 30072063 DOI: 10.1016/j.ncl.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
72 Fleischer T, Edvardsen H, Solvang HK, Daviaud C, Naume B, Børresen-Dale AL, Kristensen VN, Tost J. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients. Int J Cancer 2014;134:2615-25. [PMID: 24395279 DOI: 10.1002/ijc.28606] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
73 Fu D, Wang Z, Li-chen, Wang B, Shen Z, Huang W, Shao Z. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat 2010;119:601-12. [DOI: 10.1007/s10549-009-0339-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
74 Kim HJ, Kim CY, Jin J, Bae MK, Kim YH, Ju W, Kim YH, Kim SC. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer. Diagn Cytopathol 2018;46:15-21. [PMID: 29063719 DOI: 10.1002/dc.23838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
75 Riebler A, Menigatti M, Song JZ, Statham AL, Stirzaker C, Mahmud N, Mein CA, Clark SJ, Robinson MD. BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach. Genome Biol 2014;15:R35. [PMID: 24517713 DOI: 10.1186/gb-2014-15-2-r35] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
76 Yuan Z, Sánchez Claros C, Suzuki M, Maggi EC, Kaner JD, Kinstlinger N, Gorecka J, Quinn TJ, Geha R, Corn A, Pastoriza J, Jing Q, Adem A, Wu H, Alemu G, Du YC, Zheng D, Greally JM, Libutti SK. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis. Oncotarget 2016;7:12633-50. [PMID: 26871472 DOI: 10.18632/oncotarget.7279] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
77 Laird-offringa IA, Sanchez-cespedes M. Epigenetic Events in Lung Cancer. IASLC Thoracic Oncology. Elsevier; 2018. pp. 104-116.e5. [DOI: 10.1016/b978-0-323-52357-8.00012-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Kumaraswamy A, Welker Leng KR, Westbrook TC, Yates JA, Zhao SG, Evans CP, Feng FY, Morgan TM, Alumkal JJ. Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer. Eur Urol 2021;80:71-81. [PMID: 33785255 DOI: 10.1016/j.eururo.2021.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Sakai E, Ohata K, Chiba H, Matsuhashi N, Doi N, Fukushima J, Endo H, Takahashi H, Tsuji S, Yagi K, Matsusaka K, Aburatani H, Nakajima A, Kaneda A. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors. Int J Cancer 2014;135:1586-95. [PMID: 24590867 DOI: 10.1002/ijc.28814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
80 de Vos L, Gevensleben H, Schröck A, Franzen A, Kristiansen G, Bootz F, Dietrich D. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients. Clin Epigenetics 2017;9:125. [PMID: 29213339 DOI: 10.1186/s13148-017-0425-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
81 Lee DY, Li KCP. Systems Diagnostics: The Systems Approach to Molecular Imaging. American Journal of Roentgenology 2009;193:287-94. [DOI: 10.2214/ajr.09.2866] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
82 Yang AS, Yang BJ. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors. Epigenomics 2016;8:9-12. [PMID: 26698294 DOI: 10.2217/epi.15.94] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
83 Tsui DW, Chiu RW, Lo YD. Epigenetic approaches for the detection of fetal DNA in maternal plasma. Chimerism 2010;1:30-5. [PMID: 21327153 DOI: 10.4161/chim.1.1.12439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
84 Shen SY, Burgener JM, Bratman SV, De Carvalho DD. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA. Nat Protoc 2019;14:2749-80. [DOI: 10.1038/s41596-019-0202-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
85 Bose P, Grant S. Rational Combinations of Targeted Agents in AML. J Clin Med 2015;4:634-64. [PMID: 26113989 DOI: 10.3390/jcm4040634] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
86 Menigatti M, Staiano T, Manser CN, Bauerfeind P, Komljenovic A, Robinson M, Jiricny J, Buffoli F, Marra G. Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions. Oncogenesis 2013;2:e56. [PMID: 23857251 DOI: 10.1038/oncsis.2013.21] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
87 Bhattacharjee D, Shenoy S, Bairy KL. DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics. Scientifica (Cairo) 2016;2016:6072357. [PMID: 27119045 DOI: 10.1155/2016/6072357] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
88 Stefanska B, Bouzelmat A, Huang J, Suderman M, Hallett M, Han ZG, Al-Mahtab M, Akbar SM, Khan WA, Raqib R, Szyf M. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes. PLoS One 2013;8:e68439. [PMID: 23950870 DOI: 10.1371/journal.pone.0068439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
89 Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, Zeleniuch-Jacquotte A. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol. 2010;34:717-723. [PMID: 20627767 DOI: 10.1016/j.canep.2010.05.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
90 Nephew KP. What will it take to obtain DNA methylation markers for early cervical cancer detection? Gynecol Oncol 2009;112:291-2. [PMID: 19150524 DOI: 10.1016/j.ygyno.2008.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
91 Goya R, Meyer IM, Marra MA. Applications of High-Throughput Sequencing. In: Rodríguez-ezpeleta N, Hackenberg M, Aransay AM, editors. Bioinformatics for High Throughput Sequencing. New York: Springer; 2012. pp. 27-53. [DOI: 10.1007/978-1-4614-0782-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S, Pang D. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol 2011;137:1245-53. [DOI: 10.1007/s00432-011-0998-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
93 Stefanska B, Salamé P, Bednarek A, Fabianowska-Majewska K. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012;107:781-790. [PMID: 21801466 DOI: 10.1017/s0007114511003631] [Cited by in Crossref: 71] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
94 Liu Y. At the dawn: cell-free DNA fragmentomics and gene regulation. Br J Cancer 2021. [PMID: 34815523 DOI: 10.1038/s41416-021-01635-z] [Reference Citation Analysis]
95 Xiang S, Xiang T, Xiao Q, Li Y, Shao B, Luo T. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer. Int J Oncol 2017;51:801-11. [PMID: 28677721 DOI: 10.3892/ijo.2017.4064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
96 Lam D, Luu PL, Song JZ, Qu W, Risbridger GP, Lawrence MG, Lu J, Trau M, Korbie D, Clark SJ, Pidsley R, Stirzaker C. Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels. Clin Epigenetics 2020;12:90. [PMID: 32571390 DOI: 10.1186/s13148-020-00880-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
97 Hudson NO, Buck-Koehntop BA. Zinc Finger Readers of Methylated DNA. Molecules 2018;23:E2555. [PMID: 30301273 DOI: 10.3390/molecules23102555] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
98 Long XH, Zhou YF, Peng AF, Zhang ZH, Chen XY, Chen WZ, Liu JM, Huang SH, Liu ZL. Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP). Tumor Biol 2015;36:3799-806. [DOI: 10.1007/s13277-014-3021-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
99 Sigalotti L, Covre A, Fratta E, Parisi G, Colizzi F, Rizzo A, Danielli R, Nicolay HJ, Coral S, Maio M. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med 2010;8:56. [PMID: 20540720 DOI: 10.1186/1479-5876-8-56] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 6.3] [Reference Citation Analysis]
100 Bhagat R, Kumar SS, Vaderhobli S, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma. Tumour Biol 2014;35:9069-78. [PMID: 24913706 DOI: 10.1007/s13277-014-2136-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
101 Cellai C, Balliu M, Laurenzana A, Guandalini L, Matucci R, Miniati D, Torre E, Nebbioso A, Carafa V, Altucci L, Romanelli MN, Paoletti F. The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells. J Cell Mol Med 2012;16:1758-65. [PMID: 22004558 DOI: 10.1111/j.1582-4934.2011.01464.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
102 Ari F, Napieralski R, Akgun O, Magdolen V, Ulukaya E. Epigenetic modulators combination with chemotherapy in breast cancer cells. Cell Biochem Funct 2021;39:571-83. [PMID: 33608886 DOI: 10.1002/cbf.3626] [Reference Citation Analysis]
103 Durso DF, Bacalini MG, do Valle ÍF, Pirazzini C, Bonafé M, Castellani G, Faria AM, Franceschi C, Garagnani P, Nardini C. Aberrant methylation patterns in colorectal cancer: a meta-analysis. Oncotarget 2017;8:12820-30. [PMID: 28086223 DOI: 10.18632/oncotarget.14590] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
104 Peters SL, Hlady RA, Opavska J, Klinkebiel D, Novakova S, Smith LM, Lewis RE, Karpf AR, Simpson MA, Wu L, Opavsky R. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol Cell Biol 2013;33:4321-33. [PMID: 24001767 DOI: 10.1128/MCB.00776-13] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
105 Aryee MJ, Wu Z, Ladd-Acosta C, Herb B, Feinberg AP, Yegnasubramanian S, Irizarry RA. Accurate genome-scale percentage DNA methylation estimates from microarray data. Biostatistics 2011;12:197-210. [PMID: 20858772 DOI: 10.1093/biostatistics/kxq055] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
106 Kosoff D, Krueger T, Lang JM. Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies. Immunotherapy 2013;5:1243-54. [PMID: 24188678 DOI: 10.2217/imt.13.116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
107 Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2013;34:2750-2756. [PMID: 23996928 DOI: 10.1093/carcin/bgt286] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
108 Aguilar CA, Craighead HG. Micro- and nanoscale devices for the investigation of epigenetics and chromatin dynamics. Nat Nanotechnol 2013;8:709-18. [PMID: 24091454 DOI: 10.1038/nnano.2013.195] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
109 Kowdley G, Srikantan S, Abdelmohsen K, Gorospe M, Khan J. Molecular biology techniques for the surgeon. World J Surg Proced 2012; 2(2): 5-15 [DOI: 10.5412/wjsp.v2.i2.5] [Reference Citation Analysis]
110 Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD, Chu FF, Pfeifer GP. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 2008;68:10280-10289. [PMID: 19074896 DOI: 10.1158/0008-5472.can-08-1957] [Cited by in Crossref: 150] [Cited by in F6Publishing: 91] [Article Influence: 11.5] [Reference Citation Analysis]
111 Kong HK, Yoon S, Park JH. The regulatory mechanism of the LY6K gene expression in human breast cancer cells. J Biol Chem 2012;287:38889-900. [PMID: 22988241 DOI: 10.1074/jbc.M112.394270] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
112 Stanzione R, Cotugno M, Bianchi F, Marchitti S, Forte M, Volpe M, Rubattu S. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms. Genes (Basel) 2020;11:E89. [PMID: 31941075 DOI: 10.3390/genes11010089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
113 Zhang Q, Li Y, Liu G, Xu X, Song X, Liang B, Li R, Xie J, Du M, Xiao L, Gan X, Huang D. Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. Biosci Rep 2009;29:47-56. [PMID: 18754758 DOI: 10.1042/BSR20080040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
114 Wagner JM, Hackanson B, Lübbert M, Jung M. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 2010;1:117-36. [PMID: 21258646 DOI: 10.1007/s13148-010-0012-4] [Cited by in Crossref: 289] [Cited by in F6Publishing: 265] [Article Influence: 24.1] [Reference Citation Analysis]
115 Ansari J, Shackelford RE, El-Osta H. Epigenetics in non-small cell lung cancer: from basics to therapeutics. Transl Lung Cancer Res 2016;5:155-71. [PMID: 27186511 DOI: 10.21037/tlcr.2016.02.02] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
116 Aichmüller CF, Iskar M, Jones DTW, Korshunov A, Radlwimmer B, Kool M, Ernst A, Pfister SM, Lichter P, Zapatka M. Pilocytic astrocytoma demethylation and transcriptional landscapes link bZIP transcription factors to immune response. Neuro Oncol 2020;22:1327-38. [PMID: 32052037 DOI: 10.1093/neuonc/noaa035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
117 Batham J, Lim PS, Rao S. SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis. Cancers (Basel) 2019;11:E1143. [PMID: 31405032 DOI: 10.3390/cancers11081143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
118 Scarpa M, Stylianou E. Epigenetics: Concepts and relevance to IBD pathogenesis. Inflamm Bowel Dis. 2012;18:1982-1996. [PMID: 22407855 DOI: 10.1002/ibd.22934] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
119 Haag T, Herkt CE, Walesch SK, Richter AM, Dammann RH. The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms. Genes Cancer 2014;5:365-74. [PMID: 25352953 DOI: 10.18632/genesandcancer.28] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
120 Da Ros S, Aresu L, Ferraresso S, Zorzan E, Gaudio E, Bertoni F, Dacasto M, Giantin M, Ahmad A. Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach. PLoS ONE 2018;13:e0208709. [DOI: 10.1371/journal.pone.0208709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Duijf PHG, Benezra R. The cancer biology of whole-chromosome instability. Oncogene 2013;32:4727-36. [DOI: 10.1038/onc.2012.616] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
122 Zhai R, Zhao Y, Su L, Cassidy L, Liu G, Christiani DC. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia 2012;14:29-33. [PMID: 22355271 DOI: 10.1593/neo.111626] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
123 Hassan N, Rutsch N, Győrffy B, Espinoza-Sánchez NA, Götte M. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. Sci Rep 2020;10:2262. [PMID: 32042016 DOI: 10.1038/s41598-020-59057-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
124 Brocato J, Costa M. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit Rev Toxicol. 2013;43:493-514. [PMID: 23844698 DOI: 10.3109/10408444.2013.794769] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
125 Kalita-de Croft P, Al-Ejeh F, McCart Reed AE, Saunus JM, Lakhani SR. 'Omics Approaches in Breast Cancer Research and Clinical Practice. Adv Anat Pathol 2016;23:356-67. [PMID: 27740960 DOI: 10.1097/PAP.0000000000000128] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
126 Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010;16:544-50. [PMID: 20418885 DOI: 10.1038/nm.2135] [Cited by in Crossref: 414] [Cited by in F6Publishing: 396] [Article Influence: 34.5] [Reference Citation Analysis]
127 Olaru AV, Cheng Y, Agarwal R, Yang J, David S, Abraham JM, Yu W, Kwon JH, Lazarev M, Brant SR. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm Bowel Dis. 2012;18:641-648. [PMID: 21830278 DOI: 10.1002/ibd.21826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
128 Bazhin AV, De Smet C, Golovastova MO, Schmidt J, Philippov PP. Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells. Exp Dermatol. 2010;19:1023-1025. [PMID: 20812967 DOI: 10.1111/j.1600-0625.2010.01126.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
129 Kalinke L, Thakrar R, Janes SM. The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers. Mol Oncol 2021;15:2544-64. [PMID: 33252175 DOI: 10.1002/1878-0261.12864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
130 Starlard-Davenport A, Kutanzi K, Tryndyak V, Word B, Lyn-Cook B. Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach. J Carcinog 2013;12:15. [PMID: 23961262 DOI: 10.4103/1477-3163.115720] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
131 Jefferson WN, Patisaul HB, Williams CJ. Reproductive consequences of developmental phytoestrogen exposure. Reproduction 2012;143:247-60. [PMID: 22223686 DOI: 10.1530/REP-11-0369] [Cited by in Crossref: 115] [Cited by in F6Publishing: 51] [Article Influence: 11.5] [Reference Citation Analysis]
132 Schwartz S, Meshorer E, Ast G. Chromatin organization marks exon-intron structure. Nat Struct Mol Biol 2009;16:990-5. [PMID: 19684600 DOI: 10.1038/nsmb.1659] [Cited by in Crossref: 419] [Cited by in F6Publishing: 397] [Article Influence: 32.2] [Reference Citation Analysis]
133 Pereira R, Benedetti R, Pérez-rodríguez S, Nebbioso A, García-rodríguez J, Carafa V, Stuhldreier M, Conte M, Rodríguez-barrios F, Stunnenberg HG, Gronemeyer H, Altucci L, de Lera ÁR. Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities. J Med Chem 2012;55:9467-91. [DOI: 10.1021/jm300618u] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
134 Yegnasubramanian S. Prostate cancer epigenetics and its clinical implications. Asian J Androl 2016;18:549-58. [PMID: 27212125 DOI: 10.4103/1008-682X.179859] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
135 Zhang S, Huang J, Lu J, Liu M, Chen X, Su S, Mo F, Zheng J. Electrochemical and Optical Biosensing Strategies for DNA Methylation Analysis. CMC 2020;27:6159-87. [DOI: 10.2174/0929867326666190903161750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, Lønning PE, Solvang H, Børresen-Dale AL, Tost J, Kristensen VN. Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors. BMC Cancer 2013;13:456. [PMID: 24093668 DOI: 10.1186/1471-2407-13-456] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
137 Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophys Rep 2018;4:178-88. [PMID: 30310855 DOI: 10.1007/s41048-018-0062-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
138 Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M. High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia. PLoS One 2012;7:e51527. [PMID: 23251566 DOI: 10.1371/journal.pone.0051527] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
139 Llanos AA, Marian C, Brasky TM, Dumitrescu RG, Liu Z, Mason JB, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG. Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues. Epigenetics 2015;10:727-35. [PMID: 26090795 DOI: 10.1080/15592294.2015.1062205] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
140 Raha P, Thomas S, Munster PN. Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance. Epigenomics 2011;3:451-70. [DOI: 10.2217/epi.11.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
141 Fantony JJ, Longo TA, Gopalakrishna A, Owusu R, Lance RS, Foo W, Inman BA, Abern MR. Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer. CBM 2017;18:381-7. [DOI: 10.3233/cbm-160261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
142 Chu F, Ren X, Chasse A, Hickman T, Zhang L, Yuh J, Smith MT, Burlingame AL. Quantitative mass spectrometry reveals the epigenome as a target of arsenic. Chem Biol Interact 2011;192:113-7. [PMID: 21075096 DOI: 10.1016/j.cbi.2010.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
143 Shimizu D, Kanda M, Tanaka H, Kobayashi D, Tanaka C, Hayashi M, Iwata N, Niwa Y, Takami H, Yamada S. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer. Sci Rep. 2017;7:42089. [PMID: 28165032 DOI: 10.1038/srep42089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
144 Shu Y, Wang B, Wang J, Wang JM, Zou SQ. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World J Gastroenterol 2011; 17(29): 3407-3419 [PMID: 21876633 DOI: 10.3748/wjg.v17.i29.3407] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
145 Jones A, Lechner M, Fourkala EO, Kristeleit R, Widschwendter M. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. Epigenomics 2010;2:9-38. [PMID: 22122746 DOI: 10.2217/epi.09.47] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
146 Diao L, Su H, Wei G, Li T, Gao Y, Zhao G, Guo Z. Prognostic Value of microRNA 502 Binding Site SNP in the 3′-Untranslated Region of the SET8 Gene in Patients with Non-Hodgkin's Lymphoma. Tumori Journal 2018;100:553-8. [DOI: 10.1177/1660.18180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
147 Zhao RC, Zhu YS, Shi Y. New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells. Pharmacol Ther 2008;119:74-82. [PMID: 18562010 DOI: 10.1016/j.pharmthera.2008.04.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
148 Devaskar SU, Raychaudhuri S. Epigenetics--a science of heritable biological adaptation. Pediatr Res 2007;61:1R-4R. [PMID: 17452883 DOI: 10.1203/pdr.0b013e31805cdbd8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
149 Kang HC, Chie EK, Kim HJ, Kim JH, Kim IH, Kim K, Shin BS, Ma E. A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage. Invest New Drugs 2019;37:1158-65. [PMID: 30793218 DOI: 10.1007/s10637-019-00730-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Pogribny IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 2008;49:9-15. [PMID: 17879298 DOI: 10.1002/em.20342] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
151 Sinčić N, Herceg Z. DNA methylation and cancer: ghosts and angels above the genes. Curr Opin Oncol 2011;23:69-76. [PMID: 21119515 DOI: 10.1097/CCO.0b013e3283412eb4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
152 Song H, Yu Z, Sun X, Feng J, Yu Q, Khan H, Zhu X, Huang L, Li M, Mok MTS, Cheng ASL, Gao Y, Feng H. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. EBioMedicine 2018;35:155-66. [PMID: 30150059 DOI: 10.1016/j.ebiom.2018.08.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
153 Kondo Y, Katsushima K, Ohka F, Natsume A, Shinjo K. Epigenetic dysregulation in glioma. Cancer Sci 2014;105:363-9. [PMID: 24843883 DOI: 10.1111/cas.12379] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
154 Roh JL, Wang XV, Manola J, Sidransky D, Forastiere AA, Koch WM. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study. Clin Cancer Res 2013;19:2528-40. [PMID: 23444219 DOI: 10.1158/1078-0432.CCR-12-3047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
155 He X, Tao S, Jin J, Hu S, Yu J. The most redundant sequences in human CpG island library are derived from mitochondrial genome. Genomics Proteomics Bioinformatics 2010;8:81-91. [PMID: 20691393 DOI: 10.1016/S1672-0229(10)60009-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Nishiyama N, Arai E, Nagashio R, Fujimoto H, Hosoda F, Shibata T, Tsukamoto T, Yokoi S, Imoto I, Inazawa J, Kanai Y. Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations. Carcinogenesis 2011;32:462-9. [PMID: 21177765 DOI: 10.1093/carcin/bgq274] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
157 Mishra VK, Johnsen SA. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression. Cell Tissue Res 2014;356:617-30. [PMID: 24833164 DOI: 10.1007/s00441-014-1912-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
158 Hou Y, Hu J, Zhou L, Liu L, Chen K, Yang X. Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis. Front Oncol 2021;11:647253. [PMID: 33869043 DOI: 10.3389/fonc.2021.647253] [Reference Citation Analysis]
159 Shah MY, Vasanthakumar A, Barnes NY, Figueroa ME, Kamp A, Hendrick C, Ostler KR, Davis EM, Lin S, Anastasi J, Le Beau MM, Moskowitz IP, Melnick A, Pytel P, Godley LA. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res 2010;70:5840-50. [PMID: 20587527 DOI: 10.1158/0008-5472.CAN-10-0847] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
160 Bravatà V, Cammarata FP, Forte GI, Minafra L. "Omics" of HER2-positive breast cancer. OMICS 2013;17:119-29. [PMID: 23421906 DOI: 10.1089/omi.2012.0099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
161 Meador JA, Su Y, Ravanat JL, Balajee AS. DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine. Carcinogenesis 2010;31:184-91. [PMID: 19933707 DOI: 10.1093/carcin/bgp284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
162 Barrera LN, Johnson IT, Bao Y, Cassidy A, Belshaw NJ. Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro. Eur J Nutr 2013;52:1327-41. [PMID: 22923034 DOI: 10.1007/s00394-012-0442-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
163 Tahara S, Tahara T, Horiguchi N, Okubo M, Terada T, Yoshida D, Funasaka K, Nakagawa Y, Shibata T, Tsukamoto T, Ohmiya N. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer. Epigenomics 2019;11:1651-9. [DOI: 10.2217/epi-2019-0091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
164 Postnikov YV, Furusawa T, Haines DC, Factor VM, Bustin M. Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Mol Cancer Res 2014;12:82-90. [PMID: 24296759 DOI: 10.1158/1541-7786.MCR-13-0392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
165 Maslov AY, Lee M, Gundry M, Gravina S, Strogonova N, Tazearslan C, Bendebury A, Suh Y, Vijg J. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Oncogene 2012;31:5172-9. [PMID: 22349820 DOI: 10.1038/onc.2012.9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
166 Kogan AA, Lapidus RG, Baer MR, Rassool FV. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment. Adv Cancer Res 2019;141:213-53. [PMID: 30691684 DOI: 10.1016/bs.acr.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
167 Pachaiyappan B, Woster PM. Design of small molecule epigenetic modulators. Bioorg Med Chem Lett 2014;24:21-32. [PMID: 24300735 DOI: 10.1016/j.bmcl.2013.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
168 Dumitrescu RG. Early Epigenetic Markers for Precision Medicine. Methods Mol Biol 2018;1856:3-17. [PMID: 30178243 DOI: 10.1007/978-1-4939-8751-1_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
169 Keyvani-Ghamsari S, Khorsandi K, Rasul A, Zaman MK. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenetics 2021;13:120. [PMID: 34051847 DOI: 10.1186/s13148-021-01107-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
170 Rozenberg JM, Shlyakhtenko A, Glass K, Rishi V, Myakishev MV, FitzGerald PC, Vinson C. All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. BMC Genomics 2008;9:67. [PMID: 18252004 DOI: 10.1186/1471-2164-9-67] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
171 Wang J, Zhu Z, Ma H. Label-Free Real-Time Detection of DNA Methylation Based on Quartz Crystal Microbalance Measurement. Anal Chem 2013;85:2096-101. [DOI: 10.1021/ac3026724] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
172 Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008;105:12979-84. [PMID: 18753622 DOI: 10.1073/pnas.0806437105] [Cited by in Crossref: 256] [Cited by in F6Publishing: 240] [Article Influence: 18.3] [Reference Citation Analysis]
173 Tavakoli Shirazi P, Eadie LN, Heatley SL, Hughes TP, Yeung DT, White DL. The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL. Br J Cancer 2020;122:455-64. [PMID: 31792348 DOI: 10.1038/s41416-019-0647-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Vendetti FP, Rudin CM. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases. Expert Opin Biol Ther 2013;13:1273-85. [PMID: 23859704 DOI: 10.1517/14712598.2013.819337] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
175 Mani S, Herceg Z. DNA Demethylating Agents and Epigenetic Therapy of Cancer. Epigenetics and Cancer, Part A. Elsevier; 2010. pp. 327-40. [DOI: 10.1016/b978-0-12-380866-0.60012-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
176 Vlaanderen J, Moore LE, Smith MT, Lan Q, Zhang L, Skibola CF, Rothman N, Vermeulen R. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med. 2010;67:136-143. [PMID: 19933307 DOI: 10.1136/oem.2008.042788] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
177 Maldonado L, Hoque MO. Epigenomics and ovarian carcinoma. Biomark Med 2010;4:543-70. [PMID: 20701443 DOI: 10.2217/bmm.10.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
178 Chan TA, Baylin SB. Epigenetic biomarkers. Curr Top Microbiol Immunol. 2012;355:189-216. [PMID: 21818705 DOI: 10.1007/82_2011_165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
179 Verma SK, Tian X, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, Romeril SP, Burgess JL, Grant SW, Brackley JA. Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. ACS Med Chem Lett. 2012;3:1091-1096. [PMID: 24900432 DOI: 10.1021/ml3003346] [Cited by in Crossref: 242] [Cited by in F6Publishing: 229] [Article Influence: 24.2] [Reference Citation Analysis]
180 Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, Sebree R, Rodgers K, Hooker CM, Franco N, Lee B, Tsai S, Delgado IE, Rudek MA, Belinsky SA, Herman JG, Baylin SB, Brock MV, Rudin CM. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 2011;1:598-607. [PMID: 22586682 DOI: 10.1158/2159-8290.CD-11-0214] [Cited by in Crossref: 438] [Cited by in F6Publishing: 268] [Article Influence: 39.8] [Reference Citation Analysis]
181 Angelin-bonnet O, Biggs PJ, Vignes M. Gene Regulatory Networks: A Primer in Biological Processes and Statistical Modelling. In: Sanguinetti G, Huynh-thu VA, editors. Gene Regulatory Networks. New York: Springer; 2019. pp. 347-83. [DOI: 10.1007/978-1-4939-8882-2_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
182 Shilpi A, Parbin S, Sengupta D, Kar S, Deb M, Rath SK, Pradhan N, Rakshit M, Patra SK. Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer. Chem Biol Interact 2015;233:122-38. [PMID: 25839702 DOI: 10.1016/j.cbi.2015.03.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
183 von Levetzow C, Jiang X, Gwye Y, von Levetzow G, Hung L, Cooper A, Hsu JH, Lawlor ER. Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One 2011;6:e19305. [PMID: 21559395 DOI: 10.1371/journal.pone.0019305] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 9.3] [Reference Citation Analysis]
184 Joo HY, Jones A, Yang C, Zhai L, Smith AD 4th, Zhang Z, Chandrasekharan MB, Sun ZW, Renfrow MB, Wang Y, Chang C, Wang H. Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. J Biol Chem 2011;286:7190-201. [PMID: 21183687 DOI: 10.1074/jbc.M110.158311] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
185 Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet. 2010;19:R152-R161. [PMID: 20729297 DOI: 10.1093/hmg/ddq353] [Cited by in Crossref: 328] [Cited by in F6Publishing: 334] [Article Influence: 27.3] [Reference Citation Analysis]
186 Yin CQ, Yuan CH, Qu Z, Guan Q, Chen H, Wang FB. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Dis Markers. 2016;2016:1427849. [PMID: 27403030 DOI: 10.1155/2016/1427849] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
187 Wang F, Ma Y, Wang H, Qin H. Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett 2017;13:1048-57. [PMID: 28454212 DOI: 10.3892/ol.2017.5593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
188 Medjkane S, Cock-rada A, Weitzman JB. Role of the SMYD3 histone methyltransferase in tumorigenesis: Local or global effects? Cell Cycle 2014;11:1865-1865. [DOI: 10.4161/cc.20415] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
189 Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours--lessons from the past. Nat Rev Clin Oncol. 2013;10:256-266. [PMID: 23546521 DOI: 10.1038/nrclinonc.2013.42] [Cited by in Crossref: 222] [Cited by in F6Publishing: 215] [Article Influence: 24.7] [Reference Citation Analysis]
190 Hu X, Tian K. [A Review of Epigenetic Modifications Regulate MicroRNA Expression in Lung Cancer]. Zhongguo Fei Ai Za Zhi 2020;23:582-8. [PMID: 32702792 DOI: 10.3779/j.issn.1009-3419.2020.102.29] [Reference Citation Analysis]
191 Hahn MA, Li AX, Wu X, Yang R, Drew DA, Rosenberg DW, Pfeifer GP. Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors. Cancer Res. 2014;74:3617-3629. [PMID: 24786786 DOI: 10.1158/0008-5472.can-13-3147] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
192 Saito Y, Hibino S, Saito H. Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol Res 2014;44:31-42. [PMID: 23617364 DOI: 10.1111/hepr.12147] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
193 Hassan SS, Maqsood N, Wang Q, Tao S, Sadaf S. A panel of epigenetically dysregulated Wnt signaling pathway genes for non-invasive diagnosis of pediatric acute lymphoblastic leukemia. Cancer Biomark 2021. [PMID: 34334378 DOI: 10.3233/CBM-200814] [Reference Citation Analysis]
194 Chu BF, Karpenko MJ, Liu Z, Aimiuwu J, Villalona-Calero MA, Chan KK, Grever MR, Otterson GA. Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small-cell lung cancer. Cancer Chemother Pharmacol 2013;71:115-21. [PMID: 23053268 DOI: 10.1007/s00280-012-1986-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
195 Su LJ, Mahabir S, Ellison GL, McGuinn LA, Reid BC. Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants. Front Genet 2011;2:91. [PMID: 22303385 DOI: 10.3389/fgene.2011.00091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
196 [DOI: 10.1145/2976749.2978355] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
197 Ibragimova I, Slifker MJ, Maradeo ME, Banumathy G, Dulaimi E, Uzzo RG, Cairns P. Genome-wide promoter methylome of small renal masses. PLoS One 2013;8:e77309. [PMID: 24204800 DOI: 10.1371/journal.pone.0077309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
198 Enzenhofer E, Kadletz L, Stanisz I, Kotowski U, Seemann R, Schmid R, Thurnher D, Heiduschka G. Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines. Head Neck 2017;39:900-7. [PMID: 28170128 DOI: 10.1002/hed.24699] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
199 Gertych A, Oh JH, Wawrowsky KA, Weisenberger DJ, Tajbakhsh J. 3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models. BMC Pharmacol Toxicol 2013;14:11. [PMID: 23394161 DOI: 10.1186/2050-6511-14-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
200 Hsieh C, Kuo P, Hsu Y, Huang Y, Tsai E, Hsu Y. Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radical Biology and Medicine 2014;67:159-70. [DOI: 10.1016/j.freeradbiomed.2013.10.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 11.6] [Reference Citation Analysis]
201 Pogribny IP, Shpyleva SI, Muskhelishvili L, Bagnyukova TV, James SJ, Beland FA. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutat Res. 2009;669:56-62. [PMID: 19442675 DOI: 10.1016/j.mrfmmm.2009.05.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
202 Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704-14. [PMID: 19763153 DOI: 10.1038/nrg2634] [Cited by in Crossref: 2136] [Cited by in F6Publishing: 2054] [Article Influence: 164.3] [Reference Citation Analysis]
203 Zhao Z, Li M, Tan X, Xu D, Liu R. Methylation patterns partition pancreatic cancer into distinct prognostic subtypes. Future Oncol 2021;17:2027-39. [PMID: 33784823 DOI: 10.2217/fon-2020-0804] [Reference Citation Analysis]
204 Valiulienė G, Treigytė G, Savickienė J, Matuzevičius D, Alksnė M, Jarašienė-burinskaja R, Bukelskienė V, Navakauskas D, Navakauskienė R. Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy. Biomedicine & Pharmacotherapy 2016;79:62-70. [DOI: 10.1016/j.biopha.2016.01.044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
205 Tian Y, Wu Y, Ni B. Signaling Pathways and Epigenetic Regulations in the Control of RORγt Expression in T Helper 17 Cells. International Reviews of Immunology 2015;34:305-17. [DOI: 10.3109/08830185.2014.911858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Choi WY, Hwang JH, Cho AN, Lee AJ, Lee J, Jung I, Cho SW, Kim LK, Kim YJ. DNA Methylation of Intragenic CpG Islands are Required for Differentiation from iPSC to NPC. Stem Cell Rev Rep 2020;16:1316-27. [PMID: 32975781 DOI: 10.1007/s12015-020-10041-6] [Reference Citation Analysis]
207 Li S, Xue L, Wang M, Qiang P, Xu H, Zhang X, Kang W, You F, Xu H, Wang Y, Liu X, Yang L, Wang X. Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma. Onco Targets Ther 2019;12:5627-38. [PMID: 31372000 DOI: 10.2147/OTT.S198567] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
208 Barrero MJ, Belmonte JCI. Polycomb complex recruitment in pluripotent stem cells. Nat Cell Biol 2013;15:348-50. [DOI: 10.1038/ncb2723] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
209 Song SH, Han SW, Bang YJ. Epigenetic-based therapies in cancer: progress to date. Drugs. 2011;71:2391-2403. [PMID: 22141383 DOI: 10.2165/11596690-000000000-00000] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
210 Zhang W, Xu Y, Ma G, Qi W, Gu H, Jiang P. Genetic Polymorphism of DNA Methyltransferase 3A rs1550117 A>G and Risk of Cancer: A Meta-analysis. Journal of Investigative Surgery 2015;28:346-53. [DOI: 10.3109/08941939.2015.1010024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
211 So JY, Skrypek N, Yang HH, Merchant AS, Nelson GW, Chen WD, Ishii H, Chen JM, Hu G, Achyut BR, Yoon EC, Han L, Huang C, Cam MC, Zhao K, Lee MP, Yang L. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization. Cancer Res 2020;80:2612-27. [PMID: 32265226 DOI: 10.1158/0008-5472.CAN-19-3339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
212 Ullah MF, Usmani S, Shah A, Abuduhier FM. Dietary molecules and experimental evidence of epigenetic influence in cancer chemoprevention: An insight. Semin Cancer Biol 2020:S1044-579X(20)30216-9. [PMID: 33152485 DOI: 10.1016/j.semcancer.2020.10.011] [Reference Citation Analysis]
213 Nielsen AY, Ormhøj M, Traynor S, Gjerstorff MF. Augmenting engineered T-cell strategies in solid cancers through epigenetic priming. Cancer Immunol Immunother 2020;69:2169-78. [PMID: 32648166 DOI: 10.1007/s00262-020-02661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Abaza MS, Bahman AM, Al-Attiyah RJ, Kollamparambil AM. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action. Tumour Biol 2012;33:1951-72. [PMID: 23011889 DOI: 10.1007/s13277-012-0456-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
215 Hattori M, Yokoyama Y, Hattori T, Motegi S, Amano H, Hatada I, Ishikawa O. Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts. Exp Dermatol 2015;24:841-6. [PMID: 26013976 DOI: 10.1111/exd.12767] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
216 Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM, Ahuja N. DNA methylation biomarker candidates for early detection of colon cancer. Tumour Biol. 2012;33:363-372. [PMID: 22238052 DOI: 10.1007/s13277-011-0302-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
217 Lin Z, Zhang X, Liu Z, Liu Q, Wang L, Lu Y, Liu Y, Wang M, Yang M, Jin X. The distinct expression patterns of claudin-2, -6, and -11 between human gastric neoplasms and adjacent non-neoplastic tissues. Diagn Pathol. 2013;8:133. [PMID: 23919729 DOI: 10.1186/1746-1596-8-133] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
218 Lam K, Pan K, Linnekamp JF, Medema JP, Kandimalla R. DNA methylation based biomarkers in colorectal cancer: A systematic review. Biochim Biophys Acta. 2016;1866:106-120. [PMID: 27385266 DOI: 10.1016/j.bbcan.2016.07.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
219 Nakamoto S, Kumamoto Y, Igarashi K, Fujiyama Y, Nishizawa N, Ei S, Tajima H, Kaizu T, Watanabe M, Yamashita K. Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma. PLoS One 2018;13:e0205864. [PMID: 30325974 DOI: 10.1371/journal.pone.0205864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
220 Mitra S, Dash R. Natural Products for the Management and Prevention of Breast Cancer. Evid Based Complement Alternat Med 2018;2018:8324696. [PMID: 29681985 DOI: 10.1155/2018/8324696] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 12.3] [Reference Citation Analysis]
221 Wu L, Shen Y, Peng X, Zhang S, Wang M, Xu G, Zheng X, Wang J, Lu C. Aberrant promoter methylation of cancer-related genes in human breast cancer. Oncol Lett 2016;12:5145-55. [PMID: 28105221 DOI: 10.3892/ol.2016.5351] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
222 Gery S, Koeffler HP. The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 2007;72:459-64. [PMID: 18419305 DOI: 10.1101/sqb.2007.72.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
223 Merlos Rodrigo MA, Jimenez Jimemez AM, Haddad Y, Bodoor K, Adam P, Krizkova S, Heger Z, Adam V. Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistance. Drug Resist Updat 2020;52:100691. [PMID: 32615524 DOI: 10.1016/j.drup.2020.100691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
224 Pinkin NK, Liu I, Abron JD, Waters ML. Secondary Binding Interactions in a Synthetic Receptor for Trimethyllysine. Chem Eur J 2015;21:17981-6. [DOI: 10.1002/chem.201502302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
225 Wu F, Hua Y, Kaochar S, Nie S, Lin YL, Yao Y, Wu J, Wu X, Fu X, Schiff R, Davis CM, Robertson M, Ehli EA, Coarfa C, Mitsiades N, Song Y. Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP. J Med Chem 2020;63:4716-31. [PMID: 32314924 DOI: 10.1021/acs.jmedchem.9b02164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
226 Vidal E, Sayols S, Moran S, Guillaumet-Adkins A, Schroeder MP, Royo R, Orozco M, Gut M, Gut I, Lopez-Bigas N, Heyn H, Esteller M. A DNA methylation map of human cancer at single base-pair resolution. Oncogene 2017;36:5648-57. [PMID: 28581523 DOI: 10.1038/onc.2017.176] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 9.6] [Reference Citation Analysis]
227 Fremd C, Jaeger D, Schneeweiss A. Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives. Expert Rev Anticancer Ther 2019;19:29-42. [PMID: 30351981 DOI: 10.1080/14737140.2019.1537785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
228 Onvani S, Etame AB, Smith CA, Rutka JT. Genetics of medulloblastoma: clues for novel therapies. Expert Rev Neurother 2010;10:811-23. [PMID: 20420498 DOI: 10.1586/ern.10.31] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
229 Ma G, Babarinde IA, Zhuang Q, Hutchins AP. Unified Analysis of Multiple ChIP-Seq Datasets. Methods Mol Biol 2021;2198:451-65. [PMID: 32822050 DOI: 10.1007/978-1-0716-0876-0_33] [Reference Citation Analysis]
230 Ye D, Xiong Y. Cancer: Suffocation of gene expression. Nature 2016;537:42-3. [PMID: 27533033 DOI: 10.1038/nature19426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
231 Zhang X, Zhang X, Sun B, Lu H, Wang D, Yuan X, Huang Z. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer. Oncol Lett 2014;8:1745-50. [PMID: 25202403 DOI: 10.3892/ol.2014.2410] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
232 Suijkerbuijk KPM, van Diest PJ, van der Wall E. Improving early breast cancer detection: focus on methylation. Ann Oncol 2011;22:24-9. [PMID: 20591821 DOI: 10.1093/annonc/mdq305] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
233 Lamadema N, Burr S, Brewer AC. Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox. Free Radical Biology and Medicine 2019;131:282-98. [DOI: 10.1016/j.freeradbiomed.2018.12.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
234 Friedrich SM, Zec HC, Wang TH. Analysis of single nucleic acid molecules in micro- and nano-fluidics. Lab Chip 2016;16:790-811. [PMID: 26818700 DOI: 10.1039/c5lc01294e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
235 Yauk C, Polyzos A, Rowan-Carroll A, Somers CM, Godschalk RW, Van Schooten FJ, Berndt ML, Pogribny IP, Koturbash I, Williams A, Douglas GR, Kovalchuk O. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc Natl Acad Sci U S A 2008;105:605-10. [PMID: 18195365 DOI: 10.1073/pnas.0705896105] [Cited by in Crossref: 209] [Cited by in F6Publishing: 179] [Article Influence: 14.9] [Reference Citation Analysis]
236 Easwaran HP, Baylin SB. Role of nuclear architecture in epigenetic alterations in cancer. Cold Spring Harb Symp Quant Biol 2010;75:507-15. [PMID: 21447817 DOI: 10.1101/sqb.2010.75.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
237 Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ, Lam N, Souza BK, Giannini G, Hager GL, Arrowsmith CH, Khan J, Appella E, Thiele CJ. Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell 2017;31:50-63. [PMID: 28073004 DOI: 10.1016/j.ccell.2016.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
238 Søes S, Daugaard IL, Sørensen BS, Carus A, Mattheisen M, Alsner J, Overgaard J, Hager H, Hansen LL, Kristensen LS. Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience 2014;1:367-74. [PMID: 25594031 DOI: 10.18632/oncoscience.42] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
239 Tommasi S, Zheng A, Yoon JI, Li AX, Wu X, Besaratinia A. Whole DNA methylome profiling in mice exposed to secondhand smoke. Epigenetics 2012;7:1302-14. [PMID: 23051858 DOI: 10.4161/epi.22453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
240 Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, Müllauer L, Dekan G, Grin Y, Lang G, End-pfützenreuter A, Steiner I, Zehetmayer S, Döme B, Arns B, Fong KM, Wright CM, Yang IA, Klepetko W, Posch M, Zielinski CC, Zöchbauer-müller S. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 2013;34:513-21. [DOI: 10.1093/carcin/bgs363] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
241 De Meyer T, Mampaey E, Vlemmix M, Denil S, Trooskens G, Renard JP, De Keulenaer S, Dehan P, Menschaert G, Van Criekinge W. Quality evaluation of methyl binding domain based kits for enrichment DNA-methylation sequencing. PLoS One 2013;8:e59068. [PMID: 23554971 DOI: 10.1371/journal.pone.0059068] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
242 Fog CK, Jensen KT, Lund AH. Chromatin-modifying proteins in cancer. APMIS 2007;115:1060-89. [PMID: 18042144 DOI: 10.1111/j.1600-0463.2007.apm_776.xml.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
243 Yi J, Wu J. Epigenetic regulation in medulloblastoma. Mol Cell Neurosci 2018;87:65-76. [PMID: 29269116 DOI: 10.1016/j.mcn.2017.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
244 Shikauchi Y, Saiura A, Kubo T, Niwa Y, Yamamoto J, Murase Y, Yoshikawa H. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol. 2009;29:1944-1958. [PMID: 19139273 DOI: 10.1128/mcb.00840-08] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
245 Tzadok S, Caspin Y, Hachmo Y, Canaani D, Dotan I. Directionality of noncoding human RNAs: how to avoid artifacts. Anal Biochem 2013;439:23-9. [PMID: 23583907 DOI: 10.1016/j.ab.2013.03.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
246 Rajavelu A, Jurkowska RZ, Fritz J, Jeltsch A. Function and disruption of DNA methyltransferase 3a cooperative DNA binding and nucleoprotein filament formation. Nucleic Acids Res 2012;40:569-80. [PMID: 21926161 DOI: 10.1093/nar/gkr753] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
247 Jones P. Development of second generation epigenetic agents. Med Chem Commun 2012;3:135-61. [DOI: 10.1039/c1md00199j] [Cited by in Crossref: 13] [Article Influence: 1.3] [Reference Citation Analysis]
248 Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget 2017;8:37740-50. [PMID: 28465481 DOI: 10.18632/oncotarget.17147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
249 Karahoca M, Momparler RL. Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin Epigenetics. 2013;5:3. [PMID: 23369223 DOI: 10.1186/1868-7083-5-3] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 13.8] [Reference Citation Analysis]
250 Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov. 2012;11:384-400. [PMID: 22498752 DOI: 10.1038/nrd3674] [Cited by in Crossref: 950] [Cited by in F6Publishing: 871] [Article Influence: 95.0] [Reference Citation Analysis]
251 Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv Clin Chem. 2010;52:145-167. [PMID: 21275343 DOI: 10.1016/s0065-2423(10)52006-7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
252 Gallois C, Laurent-Puig P, Taieb J. Methylator phenotype in colorectal cancer: A prognostic factor or not? Crit Rev Oncol Hematol. 2016;99:74-80. [PMID: 26702883 DOI: 10.1016/j.critrevonc.2015.11.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
253 Rousseaux S, Reynoird N, Escoffier E, Thevenon J, Caron C, Khochbin S. Epigenetic reprogramming of the male genome during gametogenesis and in the zygote. Reprod Biomed Online 2008;16:492-503. [PMID: 18413057 DOI: 10.1016/s1472-6483(10)60456-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
254 Hayashi T, Shimamura Y, Saegusa T, Horiuchi A, Kobayashi Y, Hiraoka N, Kanai Y, Aburatani H, Sano K, Konishi I. Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression. Gene Regul Syst Bio 2008;2:297-305. [PMID: 19787091 DOI: 10.4137/grsb.s470] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Zhou XQ, Sun Q, Jiang L, Li ST, Gu W, Tian JL, Liu X, Yan SP. Synthesis, characterization, DNA/BSA interactions and anticancer activity of achiral and chiral copper complexes. Dalton Trans 2015;44:9516-27. [PMID: 25919814 DOI: 10.1039/c5dt00931f] [Cited by in Crossref: 39] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
256 Abbaszadegan MR, Taghehchian N, Li L, Aarabi A, Moghbeli M. Contribution of KCTD12 to esophageal squamous cell carcinoma. BMC Cancer 2018;18:853. [PMID: 30157793 DOI: 10.1186/s12885-018-4765-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
257 Smith J, Sen S, Weeks RJ, Eccles MR, Chatterjee A. Promoter DNA Hypermethylation and Paradoxical Gene Activation. Trends Cancer 2020;6:392-406. [PMID: 32348735 DOI: 10.1016/j.trecan.2020.02.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
258 Símová J, Polláková V, Indrová M, Mikyšková R, Bieblová J, Stěpánek I, Bubeník J, Reiniš M. Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. Br J Cancer 2011;105:1533-41. [PMID: 22015556 DOI: 10.1038/bjc.2011.428] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
259 Pettit K, Odenike O. Novel Therapies for Myelofibrosis. Curr Hematol Malig Rep 2017;12:611-24. [PMID: 29098608 DOI: 10.1007/s11899-017-0403-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
260 Zou LJ, Xiang QP, Xue XQ, Zhang C, Li CC, Wang C, Li Q, Wang R, Wu S, Zhou YL, Zhang Y, Xu Y. Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer. Acta Pharmacol Sin 2019;40:1436-47. [PMID: 31097763 DOI: 10.1038/s41401-019-0237-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
261 Fonseca AL, Healy J, Kunstman JW, Korah R, Carling T. Gene expression and regulation in adrenocortical tumorigenesis. Biology (Basel) 2012;2:26-39. [PMID: 24832650 DOI: 10.3390/biology2010026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Grant S. Targeting histone demethylases in cancer therapy. Clin Cancer Res 2009;15:7111-3. [PMID: 19934292 DOI: 10.1158/1078-0432.CCR-09-2399] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
263 Eder K, Kalman B. Molecular heterogeneity of glioblastoma and its clinical relevance. Pathol Oncol Res 2014;20:777-87. [PMID: 25156108 DOI: 10.1007/s12253-014-9833-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
264 Siegel EM, Eschrich S, Winter K, Riggs B, Berglund A, Ajidahun A, Simko J, Moughan J, Ajani J, Magliocco A, Elahi A, Hoffe S, Shibata D. Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study. Dis Colon Rectum 2014;57:941-57. [PMID: 25003289 DOI: 10.1097/DCR.0000000000000160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
265 Pourteimoor V, Paryan M, Mohammadi‐yeganeh S. microRNA as a systemic intervention in the specific breast cancer subtypes with C‐MYC impacts; introducing subtype‐based appraisal tool. J Cell Physiol 2018;233:5655-69. [DOI: 10.1002/jcp.26399] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
266 Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruïne AP, Herman JG, van Engeland M. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis 2009;30:1041-8. [PMID: 19329758 DOI: 10.1093/carcin/bgp073] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
267 Kaye FJ. Defining a candidate lung cancer gene. J Natl Cancer Inst 2008;100:1564-5. [PMID: 19001597 DOI: 10.1093/jnci/djn381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
268 Sun L, Sun X, Xu X, Zhu M, Wu Z, Shen J, Wu J, Huang Q, Li E, Xu L. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma. Acta Histochemica 2013;115:56-62. [DOI: 10.1016/j.acthis.2012.04.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
269 Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, Sherman MH, Liu SJ, Dawson DW, Williams KE, Lanasa M, Liyanarachchi S, Lin TS, Marcucci G, Pekarsky Y, Davuluri R, Croce CM, Guttridge DC, Teitell MA, Byrd JC, Plass C. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2009;106:13433-8. [PMID: 19666576 DOI: 10.1073/pnas.0906455106] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
270 She X, Rohl CA, Castle JC, Kulkarni AV, Johnson JM, Chen R. Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics 2009;10:269. [PMID: 19534766 DOI: 10.1186/1471-2164-10-269] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
271 Morel D, Almouzni G, Soria J, Postel-vinay S. Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism. Annals of Oncology 2017;28:254-69. [DOI: 10.1093/annonc/mdw552] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
272 Drogaris P, Wurtele H, Masumoto H, Verreault A, Thibault P. Comprehensive Profiling of Histone Modifications Using a Label-Free Approach and Its Applications in Determining Structure−Function Relationships. Anal Chem 2008;80:6698-707. [DOI: 10.1021/ac800739d] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
273 Yi JM. DNA Methylation Change Profiling of Colorectal Disease: Screening towards Clinical Use. Life (Basel) 2021;11:412. [PMID: 33946400 DOI: 10.3390/life11050412] [Reference Citation Analysis]
274 Kutanzi K, Kovalchuk O. Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats. Cancer Biol Ther 2013;14:564-73. [PMID: 23792640 DOI: 10.4161/cbt.24599] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
275 Moutinho C, Esteller M. MicroRNAs and Epigenetics. miRNA and Cancer. Elsevier; 2017. pp. 189-220. [DOI: 10.1016/bs.acr.2017.06.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
276 Ross SA, Dwyer J, Umar A, Kagan J, Verma M, Van Bemmel DM, Dunn BK. Introduction: diet, epigenetic events and cancer prevention. Nutr Rev 2008;66 Suppl 1:S1-6. [PMID: 18673478 DOI: 10.1111/j.1753-4887.2008.00055.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
277 Li L, Li W. Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacology & Therapeutics 2015;150:33-46. [DOI: 10.1016/j.pharmthera.2015.01.004] [Cited by in Crossref: 161] [Cited by in F6Publishing: 173] [Article Influence: 23.0] [Reference Citation Analysis]
278 Dechassa ML, Tryndyak V, de Conti A, Xiao W, Beland FA, Pogribny IP. Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma. Molecular Carcinogenesis 2018;57:978-87. [DOI: 10.1002/mc.22818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
279 Mascolo M, Ilardi G, Merolla F, Russo D, Vecchione ML, de Rosa G, Staibano S. Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker. Int J Mol Sci 2012;13:11044-62. [PMID: 23109837 DOI: 10.3390/ijms130911044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
280 Yamashita M, Toyota M, Suzuki H, Nojima M, Yamamoto E, Kamimae S, Watanabe Y, Kai M, Akashi H, Maruyama R, Sasaki Y, Yamano H, Sugai T, Shinomura Y, Imai K, Tokino T, Itoh F. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci 2010;101:1708-16. [PMID: 20507321 DOI: 10.1111/j.1349-7006.2010.01581.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
281 Sakai E, Nakajima A, Kaneda A. Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol 2014; 20(4): 978-987 [PMID: 24574770 DOI: 10.3748/wjg.v20.i4.978] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
282 Tsang YH, Lamb A, Chen LF. New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection. J Cell Biochem 2011;112:381-6. [PMID: 21268057 DOI: 10.1002/jcb.22964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
283 Fu Y, Nachtigal MW. Analysis of epigenetic alterations to proprotein convertase genes in disease. Methods Mol Biol 2011;768:231-45. [PMID: 21805246 DOI: 10.1007/978-1-61779-204-5_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
284 Pop S, Enciu AM, Tarcomnicu I, Gille E, Tanase C. Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation. Phytochem Rev 2019;18:1005-24. [DOI: 10.1007/s11101-019-09627-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
285 Wang Y, Zhang Y, Herman JG, Linghu E, Guo M. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development. Oncotarget 2017;8:70035-48. [PMID: 29050260 DOI: 10.18632/oncotarget.19550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
286 Azangou-Khyavy M, Ghasemi M, Khanali J, Boroomand-Saboor M, Jamalkhah M, Soleimani M, Kiani J. CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer. Front Immunol 2020;11:2062. [PMID: 33117331 DOI: 10.3389/fimmu.2020.02062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
287 Lee PS, Teaberry VS, Bland AE, Huang Z, Whitaker RS, Baba T, Fujii S, Secord AA, Berchuck A, Murphy SK. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer. Int J Cancer. 2010;126:1378-1389. [PMID: 19642140 DOI: 10.1002/ijc.24797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 25] [Article Influence: 0.5] [Reference Citation Analysis]
288 Conti Ad, Kobets T, Escudero-Lourdes C, Montgomery B, Tryndyak V, Beland FA, Doerge DR, Pogribny IP. Dose- and time-dependent epigenetic changes in the livers of Fisher 344 rats exposed to furan. Toxicol Sci 2014;139:371-80. [PMID: 24614236 DOI: 10.1093/toxsci/kfu044] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
289 Low JS, Tao Q, Ng KM, Goh HK, Shu XS, Woo WL, Ambinder RF, Srivastava G, Shamay M, Chan AT, Popescu NC, Hsieh WS. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene 2011;30:1923-35. [PMID: 21217778 DOI: 10.1038/onc.2010.576] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
290 Raddatz G, Gao Q, Bender S, Jaenisch R, Lyko F. Dnmt3a protects active chromosome domains against cancer-associated hypomethylation. PLoS Genet 2012;8:e1003146. [PMID: 23284304 DOI: 10.1371/journal.pgen.1003146] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
291 Bai L, Yang G, Qin Z, Lyu J, Wang Y, Feng J, Liu M, Gong T, Li X, Li Z, Li J, Qin J, Yang W, Ding C. Proteome-Wide Profiling of Readers for DNA Modification. Adv Sci (Weinh) 2021;:e2101426. [PMID: 34351703 DOI: 10.1002/advs.202101426] [Reference Citation Analysis]
292 Ratsch BA, Grau M, Dörken B, Lenz P, Lenz G. The use of microarray technologies in mantle cell lymphoma. Semin Hematol 2011;48:166-71. [PMID: 21782058 DOI: 10.1053/j.seminhematol.2011.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
293 Racanelli AC, Turner FB, Xie LY, Taylor SM, Moran RG. A mouse gene that coordinates epigenetic controls and transcriptional interference to achieve tissue-specific expression. Mol Cell Biol 2008;28:836-48. [PMID: 17998333 DOI: 10.1128/MCB.01088-07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
294 Balch C, Fang F, Matei DE, Huang TH, Nephew KP. Minireview: epigenetic changes in ovarian cancer. Endocrinology 2009;150:4003-11. [PMID: 19574400 DOI: 10.1210/en.2009-0404] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 8.1] [Reference Citation Analysis]
295 Candiloro IL, Mikeska T, Hokland P, Dobrovic A. Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin 2008;1:7. [PMID: 19014416 DOI: 10.1186/1756-8935-1-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
296 Zhang J, Chen YL, Ji G, Fang W, Gao Z, Liu Y, Wang J, Ding X, Gao F. Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells. PLoS One 2013;8:e64954. [PMID: 23741434 DOI: 10.1371/journal.pone.0064954] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
297 Ibragimova I, Cairns P. Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy. Methods Mol Biol 2011;780:277-91. [PMID: 21870267 DOI: 10.1007/978-1-61779-270-0_17] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
298 Patel JN, McLeod HL, Innocenti F. Implications of genome-wide association studies in cancer therapeutics. Br J Clin Pharmacol 2013;76:370-80. [PMID: 23701381 DOI: 10.1111/bcp.12166] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
299 Hennessey PT, Ochs MF, Mydlarz WW, Hsueh W, Cope L, Yu W, Califano JA. Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts. PLoS One 2011;6:e20584. [PMID: 21637785 DOI: 10.1371/journal.pone.0020584] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
300 Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer. 2010;20:513-519. [PMID: 20442585 DOI: 10.1111/igc.0b013e3181c7fe6e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
301 Legakis I, Syrigos K. Recent advances in molecular diagnosis of thyroid cancer. J Thyroid Res 2011;2011:384213. [PMID: 21603167 DOI: 10.4061/2011/384213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
302 Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, Esopi D, Irizarry RA, Getzenberg RH, Nelson WG, Luo J, Xu J, Isaacs WB, Bova GS, Yegnasubramanian S. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5:169ra10. [PMID: 23345608 DOI: 10.1126/scitranslmed.3005211] [Cited by in Crossref: 168] [Cited by in F6Publishing: 162] [Article Influence: 18.7] [Reference Citation Analysis]
303 Xunyi Y, Zhentao Y, Dandan J, Funian L. Clinicopathological significance of PTPN12 expression in human breast cancer. Braz J Med Biol Res 2012;45:1334-40. [PMID: 23044628 DOI: 10.1590/s0100-879x2012007500163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
304 Boyle P, Clement K, Gu H, Smith ZD, Ziller M, Fostel JL, Holmes L, Meldrim J, Kelley F, Gnirke A, Meissner A. Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biol 2012;13:R92. [PMID: 23034176 DOI: 10.1186/gb-2012-13-10-r92] [Cited by in Crossref: 178] [Cited by in F6Publishing: 152] [Article Influence: 17.8] [Reference Citation Analysis]
305 Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Chili E, Del Prete P, Bacchi-Reggiani L, Cuppini A. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Med Hypotheses. 2012;79:678-697. [PMID: 22959312 DOI: 10.1016/j.mehy.2012.08.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
306 Schoorlemmer J, Macías-Redondo S, Strunk M, Ramos-Ruíz R, Calvo P, Benito R, Paules C, Oros D. Altered DNA methylation in human placenta after (suspected) preterm labor. Epigenomics 2020;12:1769-82. [PMID: 33107765 DOI: 10.2217/epi-2019-0346] [Reference Citation Analysis]
307 Madabushi A, Hwang BJ, Jin J, Lu AL. Histone deacetylase SIRT1 modulates and deacetylates DNA base excision repair enzyme thymine DNA glycosylase. Biochem J 2013;456:89-98. [PMID: 23952905 DOI: 10.1042/BJ20130670] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
308 Bi H, Liu Y, Pu R, Xia T, Sun H, Huang H, Zhang L, Zhang Y, Liu Y, Xu J, Rong J, Zhao Y. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk. Dig Dis Sci 2019;64:2158-66. [PMID: 30815821 DOI: 10.1007/s10620-019-05530-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
309 Habbe N, Bert T, Simon B. Identification of Methylation-Associated Gene Expression in Neuroendocrine Pancreatic Tumor Cells. Pancreatology 2007;7:352-9. [DOI: 10.1159/000107270] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
310 Liao H, Liao M, Xu L, Yan X, Ren B, Zhu Z, Yuan K, Zeng Y. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine 2019;41:310-9. [PMID: 30665854 DOI: 10.1016/j.ebiom.2019.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
311 Pietanza MC, Rudin CM. Novel therapeutic approaches for small cell lung cancer: the future has arrived. Curr Probl Cancer 2012;36:156-73. [PMID: 22495056 DOI: 10.1016/j.currproblcancer.2012.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
312 Ouyang J, Zhan X, Guo S, Cai S, Lei J, Zeng S, Yu L. Progress and trends on the analysis of nucleic acid and its modification. Journal of Pharmaceutical and Biomedical Analysis 2020;191:113589. [DOI: 10.1016/j.jpba.2020.113589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Kinyamu HK, Jefferson WN, Archer TK. Intersection of nuclear receptors and the proteasome on the epigenetic landscape. Environ Mol Mutagen 2008;49:83-95. [PMID: 18095329 DOI: 10.1002/em.20360] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
314 Fiedler D, Hirsch D, El Hajj N, Yang HH, Hu Y, Sticht C, Nanda I, Belle S, Rueschoff J, Lee MP, Ried T, Haaf T, Gaiser T. Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes. Genes Chromosomes Cancer 2019;58:783-97. [PMID: 31334584 DOI: 10.1002/gcc.22787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
315 Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 2009;28:209-218. [PMID: 18836486 DOI: 10.1038/onc.2008.374] [Cited by in Crossref: 276] [Cited by in F6Publishing: 260] [Article Influence: 19.7] [Reference Citation Analysis]
316 Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, Kao HY, Xu Y, Willis J, Markowitz SD, Sedwick D, Ewing RM, Wang Z. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 2010;3:ra80. [PMID: 21045206 DOI: 10.1126/scisignal.2001462] [Cited by in Crossref: 178] [Cited by in F6Publishing: 200] [Article Influence: 14.8] [Reference Citation Analysis]
317 Esteller M. Cancer Epigenetics for the 21st Century: What’s Next? Genes Cancer. 2011;2:604-606. [PMID: 21941616 DOI: 10.1177/1947601911423096] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
318 Xiang Y, Cheng Y, Li X, Li Q, Xu J, Zhang J, Liu Y, Xing Q, Wang L, He L, Zhao X. Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia. PLoS One 2013;8:e59753. [PMID: 23544093 DOI: 10.1371/journal.pone.0059753] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
319 Iqbal K, Jin SG, Pfeifer GP, Szabó PE. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci USA. 2011;108:3642-3647. [PMID: 21321204 DOI: 10.1073/pnas.1014033108] [Cited by in Crossref: 510] [Cited by in F6Publishing: 466] [Article Influence: 46.4] [Reference Citation Analysis]
320 Gehling VS, Vaswani RG, Nasveschuk CG, Duplessis M, Iyer P, Balasubramanian S, Zhao F, Good AC, Campbell R, Lee C, Dakin LA, Cook AS, Gagnon A, Harmange JC, Audia JE, Cummings RT, Normant E, Trojer P, Albrecht BK. Discovery, design, and synthesis of indole-based EZH2 inhibitors. Bioorg Med Chem Lett 2015;25:3644-9. [PMID: 26189078 DOI: 10.1016/j.bmcl.2015.06.056] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
321 Thompson RF, Suzuki M, Lau KW, Greally JM. A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry. Bioinformatics 2009;25:2164-70. [PMID: 19561019 DOI: 10.1093/bioinformatics/btp382] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
322 Hazeldine S, Pachaiyappan B, Steinbergs N, Nowotarski S, Hanson AS, Casero RA Jr, Woster PM. Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1. J Med Chem 2012;55:7378-91. [PMID: 22876979 DOI: 10.1021/jm3002845] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
323 Zhang JF, Mao ZB, Li ZL, Xue SM, Zhu HJ, Zhang H, Ni RZ. Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis. Med Oncol 2012;29:1748-57. [PMID: 21972003 DOI: 10.1007/s12032-011-0067-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
324 Kelemen LE, Köbel M, Chan A, Taghaddos S, Dinu I. Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue. Biomed Res Int 2013;2013:815894. [PMID: 24175302 DOI: 10.1155/2013/815894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
325 Park JK, Seo JS, Lee SK, Chan KK, Kuh HJ. Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells. Biomol Ther (Seoul) 2018;26:591-8. [PMID: 30173503 DOI: 10.4062/biomolther.2018.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
326 Song X, Wang J, Zheng T, Song R, Liang Y, Bhatta N, Yin D, Pan S, Liu J, Jiang H, Liu L. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. Mol Cancer. 2013;12:114. [PMID: 24093956 DOI: 10.1186/1476-4598-12-114] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
327 Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z. Nanoparticles: A Promising Modality in the Treatment of Sarcomas. Pharm Res 2011;28:260-72. [DOI: 10.1007/s11095-010-0173-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
328 Zhao Q, Li S, Li N, Yang X, Ma S, Yang A, Zhang H, Yang S, Mao C, Xu L, Gao T, Yang X, Zhang H, Jiang Y. miR-34a Targets HDAC1-Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells. J Cell Biochem. 2017;118:4617-4627. [PMID: 28485501 DOI: 10.1002/jcb.26126] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
329 Scott A, Song J, Ewing R, Wang Z. Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications. Acta Biochim Biophys Sin (Shanghai) 2014;46:199-203. [PMID: 24389641 DOI: 10.1093/abbs/gmt146] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
330 Loring HS, Thompson PR. Kinetic Mechanism of Nicotinamide N-Methyltransferase. Biochemistry 2018;57:5524-32. [PMID: 30148963 DOI: 10.1021/acs.biochem.8b00775] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
331 Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Emerging targets for glioblastoma stem cell therapy. J Biomed Res 2016;30:19-31. [PMID: 26616589 DOI: 10.7555/JBR.30.20150100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
332 Olden K, Olden HA, Lin YS. The Role of the Epigenome in Translating Neighborhood Disadvantage Into Health Disparities. Curr Environ Health Rep 2015;2:163-70. [PMID: 26231365 DOI: 10.1007/s40572-015-0048-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
333 Zhu D, Hunter SB, Vertino PM, Van Meir EG. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Res 2011;71:5859-70. [PMID: 21724586 DOI: 10.1158/0008-5472.CAN-11-1157] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
334 Qian S, Lv X, Scheid RN, Lu L, Yang Z, Chen W, Liu R, Boersma MD, Denu JM, Zhong X, Du J. Dual recognition of H3K4me3 and H3K27me3 by a plant histone reader SHL. Nat Commun 2018;9:2425. [PMID: 29930355 DOI: 10.1038/s41467-018-04836-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
335 Karaman EF, Ozden S. Alterations in global DNA methylation and metabolism-related genes caused by zearalenone in MCF7 and MCF10F cells. Mycotoxin Res 2019;35:309-20. [PMID: 30953299 DOI: 10.1007/s12550-019-00358-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
336 Pimson C, Ekalaksananan T, Pientong C, Promthet S, Putthanachote N, Suwanrungruang K, Wiangnon S. Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer. PeerJ 2016;4:e2112. [PMID: 27330867 DOI: 10.7717/peerj.2112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
337 Chen H, Hardy TM, Tollefsbol TO. Epigenomics of ovarian cancer and its chemoprevention. Front Genet 2011;2:67. [PMID: 22303362 DOI: 10.3389/fgene.2011.00067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
338 Husni RE, Shiba-Ishii A, Nakagawa T, Dai T, Kim Y, Hong J, Sakashita S, Sakamoto N, Sato Y, Noguchi M. DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma. Oncotarget 2019;10:1625-36. [PMID: 30899432 DOI: 10.18632/oncotarget.26676] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
339 Yamada Y, Watanabe A. Epigenetic Codes in Stem Cells and Cancer Stem Cells. Epigenetics and Cancer, Part A. Elsevier; 2010. pp. 177-99. [DOI: 10.1016/b978-0-12-380866-0.60007-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
340 Zaidi SK, Young DW, Montecino MA, Lian JB, van Wijnen AJ, Stein JL, Stein GS. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 2010;11:583-9. [PMID: 20628351 DOI: 10.1038/nrg2827] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 8.3] [Reference Citation Analysis]
341 Singh RR, Bains A, Patel KP, Rahimi H, Barkoh BA, Paladugu A, Bisrat T, Ravandi-Kashani F, Cortes JE, Kantarjian HM, Medeiros LJ, Luthra R. Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis. J Mol Diagn 2012;14:336-45. [PMID: 22642896 DOI: 10.1016/j.jmoldx.2012.02.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
342 Matei DE, Nephew KP. Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. Gynecol Oncol. 2010;116:195-201. [PMID: 19854495 DOI: 10.1016/j.ygyno.2009.09.043] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
343 Zakhari S, Hoek JB. Alcohol and breast cancer: reconciling epidemiological and molecular data. Adv Exp Med Biol 2015;815:7-39. [PMID: 25427899 DOI: 10.1007/978-3-319-09614-8_2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
344 Schulz WA. Do DNA-methylation changes also occur in blood? Lancet Oncol 2008;9:312-3. [PMID: 18374285 DOI: 10.1016/S1470-2045(08)70083-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
345 Haag T, Richter AM, Schneider MB, Jiménez AP, Dammann RH. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms. BMC Cancer 2016;16:49. [PMID: 26833217 DOI: 10.1186/s12885-016-2087-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
346 Amin SA, Adhikari N, Jha T. Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies? Pharmacological Research 2017;122:8-19. [DOI: 10.1016/j.phrs.2017.05.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
347 Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet. 2011;43:875-878. [PMID: 21822268 DOI: 10.1038/ng.907] [Cited by in Crossref: 503] [Cited by in F6Publishing: 482] [Article Influence: 45.7] [Reference Citation Analysis]
348 Lee JC, Lee WH, Min YJ, Cha HJ, Han MW, Chang HW, Kim SA, Choi SH, Kim SW, Kim SY. Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2014;88:1203-11. [PMID: 24661673 DOI: 10.1016/j.ijrobp.2013.12.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
349 Liu Y, Gu Y, Su M, Liu H, Zhang S, Zhang Y. An analysis about heterogeneity among cancers based on the DNA methylation patterns. BMC Cancer 2019;19:1259. [PMID: 31888612 DOI: 10.1186/s12885-019-6455-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
350 Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat Biotechnol. 2010;28:1069-1078. [PMID: 20944599 DOI: 10.1038/nbt.1678] [Cited by in Crossref: 532] [Cited by in F6Publishing: 479] [Article Influence: 76.0] [Reference Citation Analysis]
351 Patra SK, Deb M, Patra A. Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenetics 2011;2:27-53. [PMID: 22704268 DOI: 10.1007/s13148-010-0016-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
352 Balliu M, Guandalini L, Romanelli MN, D'Amico M, Paoletti F. HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. J Cell Mol Med 2015;19:143-54. [PMID: 25376115 DOI: 10.1111/jcmm.12345] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
353 Lin B, Hui J, Mao H. Nanopore Technology and Its Applications in Gene Sequencing. Biosensors (Basel) 2021;11:214. [PMID: 34208844 DOI: 10.3390/bios11070214] [Reference Citation Analysis]
354 Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, Wang Y, Marquez VE, Cho YJ, Pomeroy SL. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro Oncol 2010;12:1244-56. [PMID: 20847082 DOI: 10.1093/neuonc/noq091] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
355 Pavlopoulou A, Kossida S. Cytosine methyltransferases as tumor markers. Curr Genomics 2010;11:568-77. [PMID: 21629434 DOI: 10.2174/138920210793360916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
356 Farman FU, Iqbal M, Azam M, Saeed M. Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer. Mol Biol Rep 2018;45:185-94. [PMID: 29417345 DOI: 10.1007/s11033-018-4151-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
357 Lerebours A, Stentiford GD, Lyons BP, Bignell JP, Derocles SAP, Rotchell JM. Genetic Alterations and Cancer Formation in a European Flatfish at Sites of Different Contaminant Burdens. Environ Sci Technol 2014;48:10448-55. [DOI: 10.1021/es502591p] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
358 Pinkin NK, N Power A, Waters ML. Late stage modification of receptors identified from dynamic combinatorial libraries. Org Biomol Chem 2015;13:10939-45. [PMID: 26384269 DOI: 10.1039/c5ob01649e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
359 Paz MM, Pritsos CA. The Molecular Toxicology of Mitomycin C. Advances in Molecular Toxicology Volume 6. Elsevier; 2012. pp. 243-99. [DOI: 10.1016/b978-0-444-59389-4.00007-0] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
360 Kaneda A, Matsusaka K, Sakai E, Funata S. DNA methylation accumulation and its predetermination of future cancer phenotypes. J Biochem 2014;156:63-72. [PMID: 24962701 DOI: 10.1093/jb/mvu038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
361 Lee MJ, Kuehne N, Hueniken K, Liang S, Rai S, Sorotsky H, Herman M, Shepshelovich D, Bruce J, Liang M, Patel D, Cheng D, Chen Z, Eng L, Brown MC, Cho J, Leighl NB, de Perrot M, Reisman D, Xu W, Bradbury PA, Liu G. Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis. Mol Carcinog 2019;58:1960-73. [PMID: 31355511 DOI: 10.1002/mc.23088] [Reference Citation Analysis]
362 Yu CH, Li Y, Zhao X, Yang SQ, Li L, Cui NX, Rong L, Yi ZC. Benzene metabolite 1,2,4-benzenetriol changes DNA methylation and histone acetylation of erythroid-specific genes in K562 cells. Arch Toxicol 2019;93:137-47. [PMID: 30327826 DOI: 10.1007/s00204-018-2333-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
363 Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi Y. Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. Blood Adv 2021;5:5507-18. [PMID: 34580726 DOI: 10.1182/bloodadvances.2021005080] [Reference Citation Analysis]
364 Redl E, Sheibani-Tezerji R, Cardona CJ, Hamminger P, Timelthaler G, Hassler MR, Zrimšek M, Lagger S, Dillinger T, Hofbauer L, Draganić K, Tiefenbacher A, Kothmayer M, Dietz CH, Ramsahoye BH, Kenner L, Bock C, Seiser C, Ellmeier W, Schweikert G, Egger G. Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis. Life Sci Alliance 2021;4:e202000794. [PMID: 33310759 DOI: 10.26508/lsa.202000794] [Reference Citation Analysis]
365 Jurkowska RZ, Jeltsch A. Silencing of gene expression by targeted DNA methylation: concepts and approaches. Methods Mol Biol 2010;649:149-61. [PMID: 20680833 DOI: 10.1007/978-1-60761-753-2_9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
366 Heng J, Guo X, Wu W, Wang Y, Li G, Chen M, Peng L, Wang S, Dai L, Tang L, Wang J. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients. PLoS One 2017;12:e0174022. [PMID: 28301567 DOI: 10.1371/journal.pone.0174022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
367 Chaikind B, Kilambi KP, Gray JJ, Ostermeier M. Targeted DNA methylation using an artificially bisected M.HhaI fused to zinc fingers. PLoS One 2012;7:e44852. [PMID: 22984575 DOI: 10.1371/journal.pone.0044852] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
368 Tan S, Sun C, Wei X, Li Y, Wu Y, Yan Z, Feng F, Wang J, Wu Y. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood. Exp Lung Res. 2013;39:182-190. [PMID: 23614702 DOI: 10.3109/01902148.2013.790096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
369 Lukas RV, Boire A, Nicholas MK. Emerging therapies for malignant glioma. Expert Rev Anticancer Ther 2007;7:S29-36. [PMID: 18076315 DOI: 10.1586/14737140.7.12s.S29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
370 Valente S, Conte M, Tardugno M, Nebbioso A, Tinari G, Altucci L, Mai A. Developing novel non-hydroxamate histone deacetylaseinhibitors: the chelidamic warhead. Med Chem Commun 2012;3:298-304. [DOI: 10.1039/c1md00249j] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
371 Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P, Vinson C. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci U S A 2010;107:20311-6. [PMID: 21059933 DOI: 10.1073/pnas.1008688107] [Cited by in Crossref: 150] [Cited by in F6Publishing: 146] [Article Influence: 12.5] [Reference Citation Analysis]
372 Hwang J, Lee Y, Shin J, Park OJ. Anti-inflammatory and Anticarcinogenic Effect of Genistein Alone or in Combination with Capsaicin in TPA-Treated Rat Mammary Glands or Mammary Cancer Cell Line. Annals of the New York Academy of Sciences 2009;1171:415-20. [DOI: 10.1111/j.1749-6632.2009.04696.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
373 Zhao Y, You W, Zheng J, Chi Y, Tang W, Du R. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals. Clin Transl Oncol 2016;18:1123-30. [DOI: 10.1007/s12094-016-1494-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
374 Teschendorff AE, Liu X, Caren H, Pollard SM, Beck S, Widschwendter M, Chen L. The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput Biol 2014;10:e1003709. [PMID: 25010556 DOI: 10.1371/journal.pcbi.1003709] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
375 Azhikina T, Kozlova A, Skvortsov T, Sverdlov E. Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues. Cancer Genet 2011;204:492-500. [PMID: 22018271 DOI: 10.1016/j.cancergen.2011.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
376 Jia BY, Yang RH, Jiao WJ, Tian KH. Investigation of the effect of P14 promoter aberrant methylation on the biological function of human lung cancer cells. Thorac Cancer 2019;10:1388-94. [PMID: 31017733 DOI: 10.1111/1759-7714.13082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
377 Deplus R, Denis H, Putmans P, Calonne E, Fourrez M, Yamamoto K, Suzuki A, Fuks F. Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation. Nucleic Acids Res 2014;42:8285-96. [PMID: 24957603 DOI: 10.1093/nar/gku522] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
378 Scholpa NE, Kolli RT, Moore M, Arnold RD, Glenn TC, Cummings BS. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer. Chem Biol Interact 2016;258:21-9. [PMID: 27543423 DOI: 10.1016/j.cbi.2016.08.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
379 Bernstein JM, Bernstein CR, West CM, Homer JJ. Molecular and cellular processes underlying the hallmarks of head and neck cancer. Eur Arch Otorhinolaryngol 2013;270:2585-93. [PMID: 23263268 DOI: 10.1007/s00405-012-2323-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
380 Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ida S, Nagai Y, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Baba H. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma. Ann Surg Oncol 2012;19:2726-32. [PMID: 22187122 DOI: 10.1245/s10434-011-2176-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
381 Kim TO, Han YK, Yi JM. Hypermethylated promoters of tumor suppressor genes were identified in Crohn's disease patients. Intest Res 2020;18:297-305. [PMID: 32019290 DOI: 10.5217/ir.2019.00105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
382 Zhang Y, Tong T. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis. Biochemical and Biophysical Research Communications 2014;453:172-8. [DOI: 10.1016/j.bbrc.2014.09.092] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
383 Zheng Z, Zeng S, Liu C, Li W, Zhao L, Cai C, Nie G, He Y. The DNA methylation inhibitor RG108 protects against noise-induced hearing loss. Cell Biol Toxicol 2021. [PMID: 33723744 DOI: 10.1007/s10565-021-09596-y] [Reference Citation Analysis]
384 Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. PLoS Genet 2016;12:e1005778. [PMID: 26890883 DOI: 10.1371/journal.pgen.1005778] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 16.2] [Reference Citation Analysis]
385 Celli BR. Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges. Proc Am Thorac Soc 2012;9:74-9. [PMID: 22550249 DOI: 10.1513/pats.201107-039MS] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
386 Collings CK, Fernandez AG, Pitschka CG, Hawkins TB, Anderson JN. Oligonucleotide sequence motifs as nucleosome positioning signals. PLoS One 2010;5:e10933. [PMID: 20532171 DOI: 10.1371/journal.pone.0010933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
387 Denis H, Ndlovu MN, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 2011;12:647-56. [PMID: 21660058 DOI: 10.1038/embor.2011.110] [Cited by in Crossref: 244] [Cited by in F6Publishing: 229] [Article Influence: 22.2] [Reference Citation Analysis]
388 Zampieri M, Passananti C, Calabrese R, Perilli M, Corbi N, De Cave F, Guastafierro T, Bacalini MG, Reale A, Amicosante G, Calabrese L, Zlatanova J, Caiafa P. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PLoS One 2009;4:e4717. [PMID: 19262751 DOI: 10.1371/journal.pone.0004717] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
389 Arif M, Senapati P, Shandilya J, Kundu TK. Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochim Biophys Acta 2010;1799:702-16. [PMID: 20965294 DOI: 10.1016/j.bbagrm.2010.10.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
390 Bashir Q, William BM, Garcia-Manero G, de Lima M. Epigenetic therapy in allogeneic hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter 2013;35:126-33. [PMID: 23741191 DOI: 10.5581/1516-8484.20130034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
391 Gao FL, Lv Y, Cao J, Zou XP, Gastroenterology DO, University TADTHOMSON, 210008 N, Province J, China. Significance of H3K27me3 expression in gastric cancer Fu-Li Gao, Ying Lv, Jun Cao, Xiao-Ping Zou. Shijie Huaren Xiaohua Zazhi 2011; 19(35): 3597-3602 [DOI: 10.11569/wcjd.v19.i35.3597] [Reference Citation Analysis]
392 Klymenko Y, Nephew KP. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. Cancers (Basel) 2018;10:E295. [PMID: 30200265 DOI: 10.3390/cancers10090295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
393 Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 2008;5:e114. [PMID: 18507500 DOI: 10.1371/journal.pmed.0050114] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 7.3] [Reference Citation Analysis]
394 Kumari S, Sharma S, Advani D, Khosla A, Kumar P, Ambasta RK. Unboxing the molecular modalities of mutagens in cancer. Environ Sci Pollut Res Int 2021. [PMID: 34611806 DOI: 10.1007/s11356-021-16726-w] [Reference Citation Analysis]
395 Weissmann C, Weber H. The interferon genes. Prog Nucleic Acid Res Mol Biol. 1986;33:251-300. [PMID: 3025923 DOI: 10.1371/journal.pone.0016080] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 2.9] [Reference Citation Analysis]
396 Gerhauser C. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top Curr Chem. 2013;329:73-132. [PMID: 22955508 DOI: 10.1007/128_2012_360] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 11.4] [Reference Citation Analysis]
397 Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Della Vittoria Scarpati G, Di Lorenzo G, Pisconti S. Epigenetic control of gene expression: Potential implications for cancer treatment. Crit Rev Oncol Hematol 2017;111:166-72. [PMID: 28259291 DOI: 10.1016/j.critrevonc.2017.01.020] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 13.4] [Reference Citation Analysis]
398 Stahl M, Kohrman N, Gore SD, Kim TK, Zeidan AM, Prebet T. Epigenetics in Cancer: A Hematological Perspective. PLoS Genet 2016;12:e1006193. [PMID: 27723796 DOI: 10.1371/journal.pgen.1006193] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 8.7] [Reference Citation Analysis]
399 Muñoz-Antonia T, Torrellas-Ruiz M, Clavell J, Mathews LA, Muro-Cacho CA, Báez A. Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma. Int J Otolaryngol 2009;2009:848695. [PMID: 20111589 DOI: 10.1155/2009/848695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
400 Al-Eitan LN, Alghamdi MA, Tarkhan AH, Al-Qarqaz FA. Epigenome-wide analysis of common warts reveals aberrant promoter methylation. Int J Med Sci 2020;17:191-206. [PMID: 32038103 DOI: 10.7150/ijms.39261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N. Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer. DNA Cell Biol. 2011;30:17-24. [PMID: 20860434 DOI: 10.1089/dna.2010.1090] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
402 Li Y, Song L, Gong Y, He B. Detection of colorectal cancer by DNA methylation biomarker SEPT9: Past, present and future. Biomark Med. 2014;8:755-769. [PMID: 25123042 DOI: 10.2217/bmm.14.8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
403 Ardura A, Zaiko A, Morán P, Planes S, Garcia-Vazquez E. Epigenetic signatures of invasive status in populations of marine invertebrates. Sci Rep 2017;7:42193. [PMID: 28205577 DOI: 10.1038/srep42193] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 8.6] [Reference Citation Analysis]
404 Oh BK, Um TH, Choi GH, Park YN. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis. Int J Cancer 2011;128:857-68. [PMID: 20473888 DOI: 10.1002/ijc.25398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
405 Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007;2:2265-75. [PMID: 17853883 DOI: 10.1038/nprot.2007.314] [Cited by in Crossref: 470] [Cited by in F6Publishing: 429] [Article Influence: 31.3] [Reference Citation Analysis]
406 Rønneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Børresen-Dale AL, Tost J, Kristensen V. Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol Oncol 2011;5:61-76. [PMID: 21212030 DOI: 10.1016/j.molonc.2010.11.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
407 Medina-Franco JL, López-Vallejo F, Kuck D, Lyko F. Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach. Mol Divers 2011;15:293-304. [PMID: 20697809 DOI: 10.1007/s11030-010-9262-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 8.2] [Reference Citation Analysis]
408 Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen HN, Shin J, Cox E, Rho HS, Woodard C, Xia S, Liu S, Lyu H, Ming GL, Wade H, Song H, Qian J, Zhu H. DNA methylation presents distinct binding sites for human transcription factors. Elife 2013;2:e00726. [PMID: 24015356 DOI: 10.7554/eLife.00726] [Cited by in Crossref: 208] [Cited by in F6Publishing: 145] [Article Influence: 23.1] [Reference Citation Analysis]
409 Najem SA, Khawaja G, Hodroj MH, Rizk S. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro. CMP 2019;12:281-300. [DOI: 10.2174/1874467212666190313154531] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
410 Deng L, Zhang L, Yao Y, Wang C, Redell MS, Dong S, Song Y. Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L. Medchemcomm 2013;4:822-6. [PMID: 23795283 DOI: 10.1039/C3MD00021D] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
411 Yamagishi M, Uchimaru K. Targeting EZH2 in cancer therapy. Curr Opin Oncol 2017;29:375-81. [PMID: 28665819 DOI: 10.1097/CCO.0000000000000390] [Cited by in Crossref: 101] [Cited by in F6Publishing: 63] [Article Influence: 20.2] [Reference Citation Analysis]
412 Han L, Hou L, Song J, Lin D, Wu L, Ge Y, Ma Z. Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation. Biotechnol Lett 2013;35:1175-81. [PMID: 23546941 DOI: 10.1007/s10529-013-1190-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
413 Casero RA Jr, Woster PM. Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 2009;52:4551-73. [PMID: 19534534 DOI: 10.1021/jm900187v] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 9.5] [Reference Citation Analysis]
414 Docherty SJ, Davis OS, Haworth CM, Plomin R, D'Souza U, Mill J. A genetic association study of DNA methylation levels in the DRD4 gene region finds associations with nearby SNPs. Behav Brain Funct 2012;8:31. [PMID: 22691691 DOI: 10.1186/1744-9081-8-31] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
415 Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Cancer Gene Ther 2021. [PMID: 34744163 DOI: 10.1038/s41417-021-00401-w] [Reference Citation Analysis]
416 Shvachko L. DNA hypomethylation as Achilles’ heel of tumorigenesis: A working hypothesis. Cell Biology International 2009;33:904-10. [DOI: 10.1016/j.cellbi.2009.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
417 Häfner N, Diebolder H, Jansen L, Hoppe I, Dürst M, Runnebaum IB. Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer. Gynecol Oncol 2011;121:224-9. [PMID: 21159370 DOI: 10.1016/j.ygyno.2010.11.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
418 Dumitrescu RG. Epigenetic targets in cancer epidemiology. Methods Mol Biol. 2009;471:457-467. [PMID: 19109794 DOI: 10.1007/978-1-59745-416-2_23] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
419 Qiao CY, Li F, Teng Y, Zhao J, Hu N, Fan YC, Wang K. Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Clin Exp Med 2018;18:51-62. [PMID: 28676943 DOI: 10.1007/s10238-017-0466-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
420 Kim D, Hah J, Wirtz D. Mechanics of the Cell Nucleus. In: Dong C, Zahir N, Konstantopoulos K, editors. Biomechanics in Oncology. Cham: Springer International Publishing; 2018. pp. 41-55. [DOI: 10.1007/978-3-319-95294-9_3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
421 Yang H, Lin H, Xu H, Zhang L, Cheng L, Wen B, Shou J, Guan K, Xiong Y, Ye D. TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites. Cell Res 2014;24:1017-20. [PMID: 24971736 DOI: 10.1038/cr.2014.81] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
422 Glaser S, Lubitz S, Loveland KL, Ohbo K, Robb L, Schwenk F, Seibler J, Roellig D, Kranz A, Anastassiadis K, Stewart AF. The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis. Epigenetics Chromatin 2009;2:5. [PMID: 19348672 DOI: 10.1186/1756-8935-2-5] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 8.9] [Reference Citation Analysis]
423 Rogers HA, Chapman R, Kings H, Allard J, Barron-Hastings J, Pajtler KW, Sill M, Pfister S, Grundy RG. Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma. Oncotarget 2018;9:36530-41. [PMID: 30559935 DOI: 10.18632/oncotarget.26370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
424 Lundstrom K. Epigenetics, Nutrition, Disease and Drug Development. Curr Drug Discov Technol 2019;16:386-91. [PMID: 29692252 DOI: 10.2174/1570163815666180419154954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
425 Han LL, Hou L, Zhou MJ, Ma ZL, Lin DL, Wu L, Ge YL. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer. J Biomed Sci 2013;20:52. [PMID: 23899187 DOI: 10.1186/1423-0127-20-52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
426 Wongtrakoongate P. Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. World J Stem Cells 2015; 7(1): 137-148 [PMID: 25621113 DOI: 10.4252/wjsc.v7.i1.137] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
427 Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenetics 2015;7:127. [PMID: 26692909 DOI: 10.1186/s13148-015-0157-2] [Cited by in Crossref: 129] [Cited by in F6Publishing: 107] [Article Influence: 18.4] [Reference Citation Analysis]
428 Zardo G, Cimino G, Nervi C. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. Leukemia 2008;22:1503-18. [PMID: 18548105 DOI: 10.1038/leu.2008.141] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
429 Singh AK, Kumar R, Pandey AK. Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers. Curr Chem Genom Transl Med. 2018;12:9-26. [PMID: 30069430 DOI: 10.2174/2213988501812010009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
430 Besaratinia A, Tommasi S. Genotoxicity of tobacco smoke‐derived aromatic amines and bladder cancer: current state of knowledge and future research directions. FASEB j 2013;27:2090-100. [DOI: 10.1096/fj.12-227074] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
431 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
432 Patil NA, Basu B, Deobagkar DD, Apte SK, Deobagkar DN. Putative DNA modification methylase DR_C0020 of Deinococcus radiodurans is an atypical SAM dependent C-5 cytosine DNA methylase. Biochim Biophys Acta Gen Subj 2017;1861:593-602. [PMID: 28038990 DOI: 10.1016/j.bbagen.2016.12.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
433 Raggi C, Invernizzi P. Methylation and liver cancer. Clin Res Hepatol Gastroenterol 2013;37:564-71. [PMID: 23806627 DOI: 10.1016/j.clinre.2013.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
434 Baylin SB. Resistance, epigenetics and the cancer ecosystem. Nat Med 2011;17:288-9. [DOI: 10.1038/nm0311-288] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
435 Vegas AJ, Bradner JE, Tang W, McPherson OM, Greenberg EF, Koehler AN, Schreiber SL. Fluorous-based small-molecule microarrays for the discovery of histone deacetylase inhibitors. Angew Chem Int Ed Engl 2007;46:7960-4. [PMID: 17868168 DOI: 10.1002/anie.200703198] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
436 Samartzis N, Imesch P, Dedes KJ, Samartzis EP, Fedier A, Fink D, Caduff R, Fehr MK. Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study. BMC Cancer 2011;11:463. [PMID: 22029821 DOI: 10.1186/1471-2407-11-463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
437 Shin Y, Kim M, Won J, Kim J, Oh SB, Lee JH, Park K. Epigenetic Modification of CFTR in Head and Neck Cancer. J Clin Med 2020;9:E734. [PMID: 32182826 DOI: 10.3390/jcm9030734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
438 Liu M, Wang J, Liu P. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276). J Pharm Biomed Anal 2016;131:429-35. [PMID: 27661436 DOI: 10.1016/j.jpba.2016.08.034] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
439 Gertych A, Wawrowsky KA, Lindsley E, Vishnevsky E, Farkas DL, Tajbakhsh J. Automated quantification of DNA demethylation effects in cells via 3D mapping of nuclear signatures and population homogeneity assessment. Cytometry A 2009;75:569-83. [PMID: 19459215 DOI: 10.1002/cyto.a.20740] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
440 Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011;3:771-84. [PMID: 22126295 DOI: 10.2217/epi.11.105] [Cited by in Crossref: 398] [Cited by in F6Publishing: 350] [Article Influence: 39.8] [Reference Citation Analysis]
441 Duthie SJ. Epigenetic modifications and human pathologies: cancer and CVD. Proc Nutr Soc 2011;70:47-56. [PMID: 21067630 DOI: 10.1017/S0029665110003952] [Cited by in Crossref: 67] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
442 Borghese B, Barbaux S, Mondon F, Santulli P, Pierre G, Vinci G, Chapron C, Vaiman D. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010;24:1872-85. [PMID: 20685852 DOI: 10.1210/me.2010-0160] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
443 Tarayrah L, Chen X. Epigenetic regulation in adult stem cells and cancers. Cell Biosci 2013;3:41. [PMID: 24172544 DOI: 10.1186/2045-3701-3-41] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
444 Mehra M, Chauhan R. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma. Biomark Cancer 2017;9:1179299X17737301. [PMID: 29147078 DOI: 10.1177/1179299X17737301] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
445 Tajbakhsh J. DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology. Epigenomics 2011;3:761-70. [PMID: 22126294 DOI: 10.2217/epi.11.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
446 Nordlund J, Milani L, Lundmark A, Lönnerholm G, Syvänen AC. DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission. PLoS One 2012;7:e34513. [PMID: 22493696 DOI: 10.1371/journal.pone.0034513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
447 Zheng Y, Huang G, Silva TC, Yang Q, Jiang YY, Koeffler HP, Lin DC, Berman BP. A pan-cancer analysis of CpG Island gene regulation reveals extensive plasticity within Polycomb target genes. Nat Commun 2021;12:2485. [PMID: 33931649 DOI: 10.1038/s41467-021-22720-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Bai X, Song Z, Fu Y, Yu Z, Zhao L, Zhao H, Yao W, Huang D, Mi X, Wang E, Zheng Z, Wei M. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer. PLoS One 2012;7:e40024. [PMID: 22768205 DOI: 10.1371/journal.pone.0040024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
449 Buscariollo DL, Fang X, Greenwood V, Xue H, Rivkees SA, Wendler CC. Embryonic caffeine exposure acts via A1 adenosine receptors to alter adult cardiac function and DNA methylation in mice. PLoS One 2014;9:e87547. [PMID: 24475304 DOI: 10.1371/journal.pone.0087547] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
450 Kumar N, Singh AK. Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications. Curr Hypertens Rev 2019;15:57-63. [PMID: 29766818 DOI: 10.2174/1573402114666180516131832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
451 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013] [Cited by in Crossref: 33789] [Cited by in F6Publishing: 31247] [Article Influence: 3071.7] [Reference Citation Analysis]
452 Yi JM, Kim TO. Epigenetic alterations in inflammatory bowel disease and cancer. Intest Res. 2015;13:112-121. [PMID: 25931995 DOI: 10.5217/ir.2015.13.2.112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
453 Tomaselli D, Lucidi A, Rotili D, Mai A. Epigenetic polypharmacology: A new frontier for epi-drug discovery. Med Res Rev 2020;40:190-244. [PMID: 31218726 DOI: 10.1002/med.21600] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
454 Balch C, Matei DE, Huang TH, Nephew KP. Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2010;2:419-47. [PMID: 22121902 DOI: 10.2217/epi.10.19] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
455 Blahnik KR, Dou L, Echipare L, Iyengar S, O'Geen H, Sanchez E, Zhao Y, Marra MA, Hirst M, Costello JF, Korf I, Farnham PJ. Characterization of the contradictory chromatin signatures at the 3' exons of zinc finger genes. PLoS One 2011;6:e17121. [PMID: 21347206 DOI: 10.1371/journal.pone.0017121] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
456 Natanzon Y, Goode EL, Cunningham JM. Epigenetics in ovarian cancer. Semin Cancer Biol 2018;51:160-9. [PMID: 28782606 DOI: 10.1016/j.semcancer.2017.08.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
457 Ramos-Lopez O, Milagro FI, Allayee H, Chmurzynska A, Choi MS, Curi R, De Caterina R, Ferguson LR, Goni L, Kang JX, Kohlmeier M, Marti A, Moreno LA, Pérusse L, Prasad C, Qi L, Reifen R, Riezu-Boj JI, San-Cristobal R, Santos JL, Martínez JA. Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity. J Nutrigenet Nutrigenomics 2017;10:43-62. [PMID: 28689206 DOI: 10.1159/000477729] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
458 Yadav M, Chatterjee P, Tolani S, Kulkarni J, Mulye M, Chauhan N, Sakhi A, Gorey S. A Nexus model of cellular transition in cancer. Biol Res 2018;51:23. [PMID: 30086794 DOI: 10.1186/s40659-018-0173-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
459 Kirsanova OV, Cherepanova NA, Gromova ES. Inhibition of C5-cytosine-DNA-methyltransferases. Biochemistry Moscow 2009;74:1175-86. [DOI: 10.1134/s0006297909110017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
460 Pan J, Zhong J, Gan LH, Chen SJ, Jin HC, Wang X, Wang LJ. Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer. Tumour Biol. 2011;32:729-735. [PMID: 21523445 DOI: 10.1007/s13277-011-0174-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
461 Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W, Robinson MD, Clark SJ. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol. 2010;12:235-246. [PMID: 20173741 DOI: 10.1038/ncb2023] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 10.0] [Reference Citation Analysis]
462 Saxena A, Dhillon VS, Shahid M, Khalil HS, Rani M, Prasad DAS T, Hedau S, Hussain A, Naqvi RA, Deo SV, Shukla NK, DAS BC, Husain SA. GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med 2012;4:1097-103. [PMID: 23226781 DOI: 10.3892/etm.2012.710] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
463 Verma M. Epigenome-Wide Association Studies (EWAS) in Cancer. Curr Genomics 2012;13:308-13. [PMID: 23204920 DOI: 10.2174/138920212800793294] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
464 Saito Y, Nakaoka T, Saito H. A New Molecular Mechanism Underlying the Antitumor Effect of DNA Methylation Inhibitors via an Antiviral Immune Response. Chromatin Remodelling and Immunity. Elsevier; 2017. pp. 227-42. [DOI: 10.1016/bs.apcsb.2016.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
465 Abe M, Yamashita S, Mori Y, Abe T, Saijo H, Hoshi K, Ushijima T, Takato T. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes. BMC Cancer 2016;16:350. [PMID: 27255271 DOI: 10.1186/s12885-016-2371-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
466 Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S, Huang C, Shankar S, Jing X, Iyer M, Hu M, Sam L, Grasso C, Maher CA, Palanisamy N, Mehra R, Kominsky HD, Siddiqui J, Yu J, Qin ZS, Chinnaiyan AM. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 2011;21:1028-41. [PMID: 21724842 DOI: 10.1101/gr.119347.110] [Cited by in Crossref: 141] [Cited by in F6Publishing: 119] [Article Influence: 12.8] [Reference Citation Analysis]
467 Jusue-Torres I, Mendoza JE, Brock MV, Hulbert A. The 100 Most Cited Papers About Cancer Epigenetics. Cureus 2020;12:e7623. [PMID: 32399356 DOI: 10.7759/cureus.7623] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
468 Flores KG, Stidley CA, Mackey AJ, Picchi MA, Stabler SP, Siegfried JM, Byers T, Berwick M, Belinsky SA, Leng S. Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers. Carcinogenesis 2012;33:1542-7. [PMID: 22665368 DOI: 10.1093/carcin/bgs194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
469 Grimm C, Chavez L, Vilardell M, Farrall AL, Tierling S, Böhm JW, Grote P, Lienhard M, Dietrich J, Timmermann B. DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer. PLoS Genet. 2013;9:e1003250. [PMID: 23408899 DOI: 10.1371/journal.pgen.1003250] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
470 Oliveira DVNP, Hentze J, O'Rourke CJ, Andersen JB, Høgdall C, Høgdall EV. DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE Samples. Reprod Sci 2021. [PMID: 33891290 DOI: 10.1007/s43032-021-00589-0] [Reference Citation Analysis]
471 Lawlor ER, Sorensen PH. Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward? Crit Rev Oncog 2015;20:155-71. [PMID: 26349414 DOI: 10.1615/critrevoncog.2015013553] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
472 Saito Y, Saito H, Liang G, Friedman JM. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 2014;47:128-35. [PMID: 24362548 DOI: 10.1007/s12016-013-8401-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
473 Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A 2008;105:252-7. [PMID: 18162535 DOI: 10.1073/pnas.0710735105] [Cited by in Crossref: 204] [Cited by in F6Publishing: 187] [Article Influence: 13.6] [Reference Citation Analysis]
474 Balassiano K, Lima S, Jenab M, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H, Meidtner K, Trichopoulou A, Laglou P, Vineis P, Panico S, Palli D, Grioni S, Tumino R, Lund E, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Ramon Quirós J, Sánchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Hallmans G, Stenling R, Ehrnström R, Regner S, Allen NE, Travis RC, Khaw KT, Offerhaus GJ, Sala N, Riboli E, Hainaut P, Scoazec JY, Sylla BS, Gonzalez CA, Herceg Z. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett 2011;311:85-95. [PMID: 21831520 DOI: 10.1016/j.canlet.2011.06.038] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
475 Chen B, Dong C, Wang F, Wu J. Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3. Onco Targets Ther 2021;14:637-51. [PMID: 33519211 DOI: 10.2147/OTT.S287464] [Reference Citation Analysis]
476 Jeziorska DM, Murray RJS, De Gobbi M, Gaentzsch R, Garrick D, Ayyub H, Chen T, Li E, Telenius J, Lynch M, Graham B, Smith AJH, Lund JN, Hughes JR, Higgs DR, Tufarelli C. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease. Proc Natl Acad Sci U S A 2017;114:E7526-35. [PMID: 28827334 DOI: 10.1073/pnas.1703087114] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 12.4] [Reference Citation Analysis]
477 Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG, Merletti F. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 2009;27:3161-8. [PMID: 19470943 DOI: 10.1200/JCO.2008.18.2485] [Cited by in Crossref: 103] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
478 Rodriguez RM, Suarez-Alvarez B, Salvanés R, Muro M, Martínez-Camblor P, Colado E, Sánchez MA, Díaz MG, Fernandez AF, Fraga MF, Lopez-Larrea C. DNA methylation dynamics in blood after hematopoietic cell transplant. PLoS One 2013;8:e56931. [PMID: 23451113 DOI: 10.1371/journal.pone.0056931] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
479 Gonzalgo ML, Liang G. Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc 2007;2:1931-6. [PMID: 17703204 DOI: 10.1038/nprot.2007.271] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
480 Rahmathulla G, Toms SA, Weil RJ. The molecular biology of brain metastasis. J Oncol 2012;2012:723541. [PMID: 22481931 DOI: 10.1155/2012/723541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
481 Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008;3:e2656. [PMID: 18628976 DOI: 10.1371/journal.pone.0002656] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 7.6] [Reference Citation Analysis]
482 Jurkowska RZ, Ceccaldi A, Zhang Y, Arimondo PB, Jeltsch A. DNA Methyltransferase Assays. In: Tollefsbol TO, editor. Epigenetics Protocols. Totowa: Humana Press; 2011. pp. 157-77. [DOI: 10.1007/978-1-61779-316-5_13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
483 Patra SK, Bettuzzi S. Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethylation. Biochemistry (. Mosc). 2009;74:613-619. [PMID: 19645665 DOI: 10.1134/s0006297909060042] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
484 Zhang J, Wen X, Liu N, Li YQ, Tang XR, Wang YQ, He QM, Yang XJ, Zhang PP, Ma J, Sun Y. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest. J Exp Clin Cancer Res 2017;36:147. [PMID: 29052525 DOI: 10.1186/s13046-017-0621-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
485 Duncan CG, Barwick BG, Jin G, Rago C, Kapoor-Vazirani P, Powell DR, Chi JT, Bigner DD, Vertino PM, Yan H. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res 2012;22:2339-55. [PMID: 22899282 DOI: 10.1101/gr.132738.111] [Cited by in F6Publishing: 116] [Reference Citation Analysis]
486 Lee ST, Muench MO, Fomin ME, Xiao J, Zhou M, de Smith A, Martín-Subero JI, Heath S, Houseman EA, Roy R, Wrensch M, Wiencke J, Metayer C, Wiemels JL. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res 2015;43:2590-602. [PMID: 25690899 DOI: 10.1093/nar/gkv103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
487 Shigaki H, Baba Y, Watanabe M, Iwagami S, Miyake K, Ishimoto T, Iwatsuki M, Baba H. LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. Ann Surg Oncol 2012;19:4238-43. [PMID: 22766991 DOI: 10.1245/s10434-012-2488-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
488 Thakur VS, Gupta K, Gupta S. The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr Pharm Biotechnol 2012;13:191-9. [PMID: 21466438 DOI: 10.2174/138920112798868584] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
489 Singh BN, Singh HB, Singh A, Naqvi AH, Singh BR. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev 2014;33:41-85. [PMID: 24390421 DOI: 10.1007/s10555-013-9457-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
490 Papoutsis AJ, Selmin OI, Borg JL, Romagnolo DF. Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol. Mol Carcinog 2015;54:261-9. [PMID: 24136580 DOI: 10.1002/mc.22095] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
491 Lizardi PM, Forloni M, Wajapeyee N. Genome-wide approaches for cancer gene discovery. Trends Biotechnol 2011;29:558-68. [PMID: 21757246 DOI: 10.1016/j.tibtech.2011.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
492 Reyngold M, Turcan S, Giri D, Kannan K, Walsh LA, Viale A, Drobnjak M, Vahdat LT, Lee W, Chan TA. Remodeling of the methylation landscape in breast cancer metastasis. PLoS One 2014;9:e103896. [PMID: 25083786 DOI: 10.1371/journal.pone.0103896] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
493 Kinyamu HK, Collins JB, Grissom SF, Hebbar PB, Archer TK. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition. Mol Carcinog 2008;47:845-85. [PMID: 18381591 DOI: 10.1002/mc.20440] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
494 Hur K, Han TS, Jung EJ, Yu J, Lee HJ, Kim WH, Goel A, Yang HK. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer. J Pathol. 2012;228:88-98. [PMID: 22653794 DOI: 10.1002/path.4055] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
495 Northcott PA, Rutka JT, Taylor MD. Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years. FOC 2010;28:E6. [DOI: 10.3171/2009.10.focus09218] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
496 Ma X, Ezzeldin HH, Diasio RB. Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 2009;69:1911-34. [PMID: 19747008 DOI: 10.2165/11315680-000000000-00000] [Cited by in Crossref: 168] [Cited by in F6Publishing: 158] [Article Influence: 12.9] [Reference Citation Analysis]
497 Hong JT. Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety. Ther Clin Risk Manag 2021;17:601-15. [PMID: 34135588 DOI: 10.2147/TCRM.S269330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
498 Lee JJ, Chu E. Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2018;17:258-273. [PMID: 30072278 DOI: 10.1016/j.clcc.2018.06.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
499 Deng JH, Deng Q, Kuo CH, Delaney SW, Ying SY. MiRNA targets of prostate cancer. Methods Mol Biol 2013;936:357-69. [PMID: 23007521 DOI: 10.1007/978-1-62703-083-0_27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
500 Pettini F, Visibelli A, Cicaloni V, Iovinelli D, Spiga O. Multi-Omics Model Applied to Cancer Genetics. Int J Mol Sci 2021;22:5751. [PMID: 34072237 DOI: 10.3390/ijms22115751] [Reference Citation Analysis]
501 Oodi A, Noruzinia M, Habibi Roudkenar M, Nikougoftar M, Soltanpour MS, Khorshidfar M, Amirizadeh N. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells. Hematology 2013;17:334-40. [DOI: 10.1179/1607845412y.0000000009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
502 Sriraksa R, Zeller C, Dai W, Siddiq A, Walley AJ, Limpaiboon T, Brown R. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors. Cancer Prev Res (Phila) 2013;6:1348-55. [PMID: 24089088 DOI: 10.1158/1940-6207.CAPR-13-0104] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
503 Li G, Zan H, Xu Z, Casali P. Epigenetics of the antibody response. Trends Immunol 2013;34:460-70. [PMID: 23643790 DOI: 10.1016/j.it.2013.03.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
504 Weisenberger DJ, Trinh BN, Campan M, Sharma S, Long TI, Ananthnarayan S, Liang G, Esteva FJ, Hortobagyi GN, McCormick F, Jones PA, Laird PW. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res 2008;36:4689-98. [PMID: 18628296 DOI: 10.1093/nar/gkn455] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 7.4] [Reference Citation Analysis]
505 Sleeman JP, Cremers N. New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment. Clin Exp Metastasis 2007;24:707-15. [DOI: 10.1007/s10585-007-9122-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
506 Papageorgiou EA, Koumbaris G, Kypri E, Hadjidaniel M, Patsalis PC. The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis. Genes (Basel). 2014;5:310-329. [PMID: 24722507 DOI: 10.3390/genes5020310] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
507 Li LZ, Deng HX, Lou WZ, Sun XY, Song MW, Tao J, Xiao BX, Guo JM. Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest. World J Gastroenterol 2012; 18(1): 79-83 [PMID: 22228974 DOI: 10.3748/wjg.v18.i1.79] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
508 Kuendgen A, Lübbert M. Current status of epigenetic treatment in myelodysplastic syndromes. Ann Hematol. 2008;87:601-611. [PMID: 18392623 DOI: 10.1007/s00277-008-0477-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
509 Lewis ZA, Adhvaryu KK, Honda S, Shiver AL, Knip M, Sack R, Selker EU. DNA methylation and normal chromosome behavior in Neurospora depend on five components of a histone methyltransferase complex, DCDC. PLoS Genet 2010;6:e1001196. [PMID: 21079689 DOI: 10.1371/journal.pgen.1001196] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
510 Ito K, Yamada Y. Cellular reprogramming technology for dissecting cancer epigenome in vivo. Epigenomics 2017;9:997-1011. [PMID: 28651445 DOI: 10.2217/epi-2017-0018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
511 Xue Y, Chen R, Du W, Yang F, Wei X. RIZ1 and histone methylation status in pituitary adenomas. Tumour Biol 2017;39:1010428317711794. [PMID: 28718376 DOI: 10.1177/1010428317711794] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
512 Fonseca AL, Kugelberg J, Starker LF, Scholl U, Choi M, Hellman P, Åkerström G, Westin G, Lifton RP, Björklund P, Carling T. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes Chromosomes Cancer 2012;51:949-60. [PMID: 22733721 DOI: 10.1002/gcc.21978] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
513 Charles MRC, Dhayalan A, Hsieh HP, Coumar MS. Insights for the design of protein lysine methyltransferase G9a inhibitors. Future Med Chem 2019;11:993-1014. [PMID: 31141392 DOI: 10.4155/fmc-2018-0396] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
514 Song JH, Yang SY, Lim JH, Choi JM, Kim SG. The Effect of Helicobacter pylori Eradication on the Metachronous Neoplasm after Endoscopic Resection for Gastric Dysplasia. Korean J Gastroenterol 2017;70:27. [DOI: 10.4166/kjg.2017.70.1.27] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
515 Kaur P, Mani S, Cros M, Scoazec J, Chemin I, Hainaut P, Herceg Z. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumor Biol 2012;33:325-36. [DOI: 10.1007/s13277-012-0331-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
516 Stanganelli C, Arbelbide J, Fantl DB, Corrado C, Slavutsky I. DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance. Ann Hematol 2010;89:191-9. [PMID: 19727727 DOI: 10.1007/s00277-009-0818-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
517 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
518 Easwaran HP, Van Neste L, Cope L, Sen S, Mohammad HP, Pageau GJ, Lawrence JB, Herman JG, Schuebel KE, Baylin SB. Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus. Cancer Res. 2010;70:8015-8024. [PMID: 20736368 DOI: 10.1158/0008-5472.can-10-0765] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
519 Horning BD, Suciu RM, Ghadiri DA, Ulanovskaya OA, Matthews ML, Lum KM, Backus KM, Brown SJ, Rosen H, Cravatt BF. Chemical Proteomic Profiling of Human Methyltransferases. J Am Chem Soc 2016;138:13335-43. [PMID: 27689866 DOI: 10.1021/jacs.6b07830] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
520 Daugaard I, Hussmann D, Kristensen L, Kristensen T, Kjeldsen TE, Nyvold CG, Larsen TS, Møller MB, Hansen LL, Wojdacz TK. Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment. Epigenomics 2018;10:1155-66. [PMID: 30182737 DOI: 10.2217/epi-2018-0020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
521 Huang LW, Pan HS, Lin YH, Seow KM, Chen HJ, Hwang JL. P16 methylation is an early event in cervical carcinogenesis. Int J Gynecol Cancer. 2011;21:452-456. [PMID: 21436693 DOI: 10.1097/igc.0b013e31821091ea] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
522 Fan H, Zhao Z, Cheng Y, Cui H, Qiao F, Wang L, Hu J, Wu H, Song W. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells. Tumour Biol 2016;37:877-85. [PMID: 26254611 DOI: 10.1007/s13277-015-3202-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
523 Todoerti K, Calice G, Trino S, Simeon V, Lionetti M, Manzoni M, Fabris S, Barbieri M, Pompa A, Baldini L, Bollati V, Zoppoli P, Neri A, Musto P. Global methylation patterns in primary plasma cell leukemia. Leukemia Research 2018;73:95-102. [DOI: 10.1016/j.leukres.2018.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
524 Yegnasubramanian S, De Marzo AM, Nelson WG. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications. Cold Spring Harb Perspect Med 2019;9:a030445. [PMID: 29959132 DOI: 10.1101/cshperspect.a030445] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
525 Matoušová M, Votruba I, Otmar M, Tloušťová E, Günterová J, Mertlíková-Kaiserová H. 2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine: a comparative study of hypomethylating potential. Epigenetics 2011;6:769-76. [PMID: 21566456 DOI: 10.4161/epi.6.6.16215] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
526 Botcheva K, McCorkle SR, McCombie WR, Dunn JJ, Anderson CW. Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle. 2011;10:4237-4249. [PMID: 22127205 DOI: 10.4161/cc.10.24.18383] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
527 Zhang RP, Shao JZ, Xiang LX. GADD45A protein plays an essential role in active DNA demethylation during terminal osteogenic differentiation of adipose-derived mesenchymal stem cells. J Biol Chem. 2011;286:41083-41094. [PMID: 21917922 DOI: 10.1074/jbc.m111.258715] [Cited by in Crossref: 69] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
528 Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V, Kalogeras KT, Fountzilas G, Grady WM. The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases. Clin Epigenetics 2017;9:46. [PMID: 28469732 DOI: 10.1186/s13148-017-0347-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
529 He M, Vanaja DK, Karnes RJ, Young CY. Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells. Prostate 2009;69:1643-50. [PMID: 19623543 DOI: 10.1002/pros.21013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
530 McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CW. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 2008;28:6223-33. [PMID: 18710953 DOI: 10.1128/MCB.00658-08] [Cited by in Crossref: 98] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
531 Chen HF, Wu KJ. Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis. Biomedicine (Taipei) 2016;6:1. [PMID: 26869355 DOI: 10.7603/s40681-016-0001-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
532 Traube FR, Schiffers S, Iwan K, Kellner S, Spada F, Müller M, Carell T. Isotope-dilution mass spectrometry for exact quantification of noncanonical DNA nucleosides. Nat Protoc 2019;14:283-312. [PMID: 30559375 DOI: 10.1038/s41596-018-0094-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
533 Milani L, Lundmark A, Nordlund J, Kiialainen A, Flaegstad T, Jonmundsson G, Kanerva J, Schmiegelow K, Gunderson KL, Lönnerholm G, Syvänen AC. Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res 2009;19:1-11. [PMID: 18997001 DOI: 10.1101/gr.083931.108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
534 Forn M, Muñoz M, Tauriello DV, Merlos-Suárez A, Rodilla V, Bigas A, Batlle E, Jordà M, Peinado MA. Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells. Mol Oncol 2013;7:1129-41. [PMID: 24035705 DOI: 10.1016/j.molonc.2013.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
535 Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta. 2014;1839:627-643. [PMID: 24631868 DOI: 10.1016/j.bbagrm.2014.03.001] [Cited by in Crossref: 416] [Cited by in F6Publishing: 345] [Article Influence: 52.0] [Reference Citation Analysis]
536 Chang C, Lin B, Chen S, Hsieh T, Li Y, Kuo MY. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma: HDAC2 promoted migration/invasion in OSCC. Journal of Oral Pathology & Medicine 2011;40:567-75. [DOI: 10.1111/j.1600-0714.2011.01009.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
537 Chen C, Pan D, Deng A, Huang F, Sun B, Yang R. DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture. Virology 2013;441:57-65. [DOI: 10.1016/j.virol.2013.03.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
538 Ponnaluri VKC, Estève PO, Ruse CI, Pradhan S. S-adenosylhomocysteine Hydrolase Participates in DNA Methylation Inheritance. J Mol Biol 2018;430:2051-65. [PMID: 29758262 DOI: 10.1016/j.jmb.2018.05.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
539 Kim D, Lee YS, Kim DH, Bae SC. Lung Cancer Staging and Associated Genetic and Epigenetic Events. Mol Cells 2020;43:1-9. [PMID: 31999917 DOI: 10.14348/molcells.2020.2246] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
540 Jelinek J, Liang S, Lu Y, He R, Ramagli LS, Shpall EJ, Estecio MR, Issa JP. Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique. Epigenetics 2012;7:1368-78. [PMID: 23075513 DOI: 10.4161/epi.22552] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
541 Chi HC, Tsai CY, Tsai MM, Lin KH. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression. Int J Mol Sci 2018;19:E555. [PMID: 29439529 DOI: 10.3390/ijms19020555] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
542 Xavier PLP, Cordeiro YG, Alexandre PA, Pires PRL, Saranholi BH, Silva ER, Müller S, Fukumasu H. An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells. Sci Rep 2019;9:17363. [PMID: 31758045 DOI: 10.1038/s41598-019-53915-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
543 Horvat M, Potočnik U, Repnik K, Kavalar R, Štabuc B. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II. Gastroenterol Res Pract 2016;2016:2139489. [PMID: 26884752 DOI: 10.1155/2016/2139489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
544 Zhou J, Wang Z, Zhang L, Gu Y, Ma Y, Li X. Association of five genetic variations in DNMT1 and DNMT3A with gastric cancer in a Chinese population. Future Oncol 2018;14:1731-9. [PMID: 29956566 DOI: 10.2217/fon-2017-0707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
545 Jones A, Joo HY, Robbins W, Wang H. Purification of histone ubiquitin ligases from HeLa cells. Methods 2011;54:315-25. [PMID: 21402158 DOI: 10.1016/j.ymeth.2011.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
546 Zhang Q, Wang HY, Liu X, Bhutani G, Kantekure K, Wasik M. IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK. Proc Natl Acad Sci U S A 2011;108:11977-82. [PMID: 21715655 DOI: 10.1073/pnas.1100319108] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
547 Cabezón M, Malinverni R, Bargay J, Xicoy B, Marcé S, Garrido A, Tormo M, Arenillas L, Coll R, Borras J, Jiménez MJ, Hoyos M, Valcárcel D, Escoda L, Vall-Llovera F, Garcia A, Font LL, Rámila E, Buschbeck M, Zamora L; CETLAM group. Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clin Epigenetics 2021;13:9. [PMID: 33446256 DOI: 10.1186/s13148-021-01002-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
548 Chandra D, Tyagi S, Singh J, Deka R, Manivannan P, Mishra P, Pati HP, Saxena R. Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients. Asian Pac J Cancer Prev 2017;18:3307-13. [PMID: 29286224 DOI: 10.22034/APJCP.2017.18.12.3307] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
549 Zhang X, Liu H, Li B, Huang P, Shao J, He Z. Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 2012;12:267. [PMID: 22727408 DOI: 10.1186/1471-2407-12-267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
550 Fernandez SV, Bingham C, Fittipaldi P, Austin L, Palazzo J, Palmer G, Alpaugh K, Cristofanilli M. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res 2014;16:445. [PMID: 25307991 DOI: 10.1186/s13058-014-0445-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
551 Schoofs T, Müller-tidow C. DNA methylation as a pathogenic event and as a therapeutic target in AML. Cancer Treatment Reviews 2011;37:S13-8. [DOI: 10.1016/j.ctrv.2011.04.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
552 Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology 2019;156:492-509. [PMID: 30404026 DOI: 10.1053/j.gastro.2018.11.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 16.3] [Reference Citation Analysis]
553 Zhang Z, Song L, Maurer K, Bagashev A, Sullivan KE. Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization. Genes Immun 2011;12:445-56. [PMID: 21451557 DOI: 10.1038/gene.2011.17] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
554 Hulf T, Sibbritt T, Wiklund ED, Patterson K, Song JZ, Stirzaker C, Qu W, Nair S, Horvath LG, Armstrong NJ, Kench JG, Sutherland RL, Clark SJ. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. Oncogene 2013;32:2891-9. [PMID: 22869146 DOI: 10.1038/onc.2012.300] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
555 Hur EH, Jung SH, Goo BK, Moon J, Choi Y, Choi DR, Chung YJ, Lee JH. Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5. Oncotarget 2017;8:11748-62. [PMID: 28052028 DOI: 10.18632/oncotarget.14342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
556 Cheng L, Zhang S, MacLennan GT, Williamson SR, Davidson DD, Wang M, Jones TD, Lopez-Beltran A, Montironi R. Laser-assisted microdissection in translational research: theory, technical considerations, and future applications. Appl Immunohistochem Mol Morphol 2013;21:31-47. [PMID: 22495368 DOI: 10.1097/PAI.0b013e31824d0519] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
557 Chen M, Shabashvili D, Nawab A, Yang SX, Dyer LM, Brown KD, Hollingshead M, Hunter KW, Kaye FJ, Hochwald SN, Marquez VE, Steeg P, Zajac-Kaye M. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer. Mol Cancer Ther 2012;11:370-82. [PMID: 22203734 DOI: 10.1158/1535-7163.MCT-11-0458] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
558 Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Tadros T, Unger ER, Rajeevan MS, Richards J, Ofotokun I, Flowers L. Pilot Study of Markers for High-grade Anal Dysplasia in a Southern Cohort From the Women's Interagency Human Immunodeficiency Virus Study. Clin Infect Dis 2020;70:1121-8. [PMID: 31058984 DOI: 10.1093/cid/ciz336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
559 Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer. 2009;115:3412-3426. [PMID: 19472401 DOI: 10.1002/cncr.24394] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
560 Casey G, Conti D, Haile R, Duggan D. Next generation sequencing and a new era of medicine. Gut 2013;62:920-32. [PMID: 22550129 DOI: 10.1136/gutjnl-2011-301935] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
561 Akhlaghipour I, Bina AR, Abbaszadegan MR, Moghbeli M. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview. Genes Environ 2021;43:14. [PMID: 33883026 DOI: 10.1186/s41021-021-00187-1] [Reference Citation Analysis]
562 Hattori N, Sako M, Kimura K, Iida N, Takeshima H, Nakata Y, Kono Y, Ushijima T. Novel prodrugs of decitabine with greater metabolic stability and less toxicity. Clin Epigenetics 2019;11:111. [PMID: 31370878 DOI: 10.1186/s13148-019-0709-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
563 Knox SS. From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer. Cancer Cell Int 2010;10:11. [PMID: 20420667 DOI: 10.1186/1475-2867-10-11] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
564 Hahn NM, Bonney PL, Dhawan D, Jones DR, Balch C, Guo Z, Hartman-Frey C, Fang F, Parker HG, Kwon EM, Ostrander EA, Nephew KP, Knapp DW. Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development. J Urol 2012;187:302-9. [PMID: 22099988 DOI: 10.1016/j.juro.2011.09.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
565 Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Mol Aspects Med 2017;54:28-36. [PMID: 27876555 DOI: 10.1016/j.mam.2016.11.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 13.5] [Reference Citation Analysis]
566 Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clin Epigenetics 2015;7:74. [PMID: 26207152 DOI: 10.1186/s13148-015-0110-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
567 Robertson KD, Bhalla KN. Missteps in "tango" for epigenome targeting. Blood 2009;114:2569-70. [PMID: 19779044 DOI: 10.1182/blood-2009-07-231662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
568 Huang TT, Gonzales CB, Gu F, Hsu YT, Jadhav RR, Wang CM, Redding SW, Tseng CE, Lee CC, Thompson IM, Chen HR, Huang TH, Kirma NB. Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas. Carcinogenesis 2013;34:1717-27. [PMID: 23568951 DOI: 10.1093/carcin/bgt112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
569 Pathiraja TN, Stearns V, Oesterreich S. Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response. J Mammary Gland Biol Neoplasia 2010;15:35-47. [PMID: 20101445 DOI: 10.1007/s10911-010-9166-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
570 He J, Han J, Liu J, Yang R, Wang J, Wang X, Chen X. Genetic and Epigenetic Impact of Chronic Inflammation on Colon Mucosa Cells. Front Genet 2021;12:722835. [PMID: 34764977 DOI: 10.3389/fgene.2021.722835] [Reference Citation Analysis]
571 Li SD, Tagami T, Ho YF, Yeang CH. Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines. BMC Syst Biol 2011;5:186. [PMID: 22051105 DOI: 10.1186/1752-0509-5-186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
572 Thomas X, Chelghoum Y, Barraco F, Troncy J. The rationale and use of hypomethylation agents in adult acute myeloid leukemia. Expert Opinion on Drug Discovery 2009;4:195-205. [DOI: 10.1517/17460440802707337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
573 Soto-Reyes E, Recillas-Targa F. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines. Oncogene 2010;29:2217-27. [PMID: 20101205 DOI: 10.1038/onc.2009.509] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
574 Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr 2010;140:1607-14. [PMID: 20631324 DOI: 10.3945/jn.110.123422] [Cited by in Crossref: 94] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
575 Ross JP, Rand KN, Molloy PL. Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2010;2:245-69. [PMID: 22121873 DOI: 10.2217/epi.10.2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
576 Siegfried Z, Simon I. DNA methylation and gene expression. WIREs Syst Biol Med 2010;2:362-71. [DOI: 10.1002/wsbm.64] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
577 Rainusso N, Man TK, Lau CC, Hicks J, Shen JJ, Yu A, Wang LL, Rosen JM. Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model. Cancer Biol Ther. 2011;12:278-287. [PMID: 21617384 DOI: 10.4161/cbt.12.4.15951] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
578 Triki H, Declerck K, Charfi S, Ben Kridis W, Chaabane K, Ben Halima S, Sellami T, Rebai A, Berghe WV, Cherif B. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia. Cancer Immunol Immunother 2021. [PMID: 34608548 DOI: 10.1007/s00262-021-03064-6] [Reference Citation Analysis]
579 Uddin MS, Mamun AA, Alghamdi BS, Tewari D, Jeandet P, Sarwar MS, Ashraf GM. Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Semin Cancer Biol 2020:S1044-579X(20)30275-3. [PMID: 33370605 DOI: 10.1016/j.semcancer.2020.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
580 Mikaelsson MA, Miller CA. The path to epigenetic treatment of memory disorders. Neurobiol Learn Mem. 2011;96:13-18. [PMID: 21320618 DOI: 10.1016/j.nlm.2011.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
581 Mazzone R, Zwergel C, Mai A, Valente S. Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy. Clin Epigenetics 2017;9:59. [PMID: 28572863 DOI: 10.1186/s13148-017-0358-y] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 16.4] [Reference Citation Analysis]
582 Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM, Casero RA Jr. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci U S A 2007;104:8023-8. [PMID: 17463086 DOI: 10.1073/pnas.0700720104] [Cited by in Crossref: 225] [Cited by in F6Publishing: 215] [Article Influence: 15.0] [Reference Citation Analysis]
583 Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab 2012;97:E1004-13. [PMID: 22472567 DOI: 10.1210/jc.2011-3298] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
584 Polepalli S, George SM, Valli Sri Vidya R, Rodrigues GS, Ramachandra L, Chandrashekar R, M DN, Rao PP, Pestell RG, Rao M. Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. The International Journal of Biochemistry & Cell Biology 2019;114:105558. [DOI: 10.1016/j.biocel.2019.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
585 Lee CC, Lin YH, Chang WH, Lin PC, Wu YC, Chang JG. Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells. BMC Cancer 2011;11:58. [PMID: 21299907 DOI: 10.1186/1471-2407-11-58] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
586 Yamamura K, Kosumi K, Baba Y, Harada K, Gao F, Zhang X, Zhou L, Kitano Y, Arima K, Kaida T, Takeyama H, Higashi T, Imai K, Hashimoto D, Chikamoto A, Tan X, Baba H. LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review. Surg Today 2017;47:1450-9. [DOI: 10.1007/s00595-017-1539-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
587 Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012;7:e41036. [PMID: 22829908 DOI: 10.1371/journal.pone.0041036] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 10.9] [Reference Citation Analysis]
588 Kling T, Wenger A, Beck S, Carén H. Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours. Clin Epigenetics 2017;9:33. [PMID: 28392843 DOI: 10.1186/s13148-017-0333-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
589 Shen Z, Chen L, Yang X, Zhao Y, Pier E, Zhang X, Yang X, Xiong Y. Downregulation of Ezh2 methyltransferase by FOXP3: New insight of FOXP3 into chromatin remodeling? Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013;1833:2190-200. [DOI: 10.1016/j.bbamcr.2013.05.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
590 Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med 2007;13:373-80. [PMID: 17822959 DOI: 10.1016/j.molmed.2007.07.004] [Cited by in Crossref: 157] [Cited by in F6Publishing: 142] [Article Influence: 10.5] [Reference Citation Analysis]
591 Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays Biochem 2019;63:797-811. [PMID: 31845735 DOI: 10.1042/EBC20190037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
592 Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res 2010;70:6968-77. [PMID: 20713525 DOI: 10.1158/0008-5472.CAN-09-4474] [Cited by in Crossref: 58] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
593 Fanelli M, Amatori S, Barozzi I, Minucci S. Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue. Nat Protoc 2011;6:1905-19. [PMID: 22082985 DOI: 10.1038/nprot.2011.406] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
594 Kim JG, Bae JH, Kim JA, Heo K, Yang K, Yi JM. Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells. PLoS One 2014;9:e105405. [PMID: 25136811 DOI: 10.1371/journal.pone.0105405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
595 Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A, Ustun C, Rao R, Fernandez P, Chen J. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009;114:2733-2743. [PMID: 19638619 DOI: 10.1182/blood-2009-03-213496] [Cited by in Crossref: 261] [Cited by in F6Publishing: 242] [Article Influence: 20.1] [Reference Citation Analysis]
596 Kachroo P, Szymczak S, Heinsen F, Forster M, Bethune J, Hemmrich-stanisak G, Baker L, Schrappe M, Stanulla M, Franke A. NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia. Epigenomics 2018;10:133-47. [DOI: 10.2217/epi-2017-0080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
597 Anderson CM, Ralph JL, Wright ML, Linggi B, Ohm JE. DNA methylation as a biomarker for preeclampsia. Biol Res Nurs 2014;16:409-20. [PMID: 24165327 DOI: 10.1177/1099800413508645] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
598 Zou Y, Li JJ, Xue W, Kong X, Duan H, Li Y, Wei L. Epigenetic Modifications and Therapy in Uveitis. Front Cell Dev Biol 2021;9:758240. [PMID: 34869347 DOI: 10.3389/fcell.2021.758240] [Reference Citation Analysis]
599 Porcellini E, Laprovitera N, Riefolo M, Ravaioli M, Garajova I, Ferracin M. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. Cancer Lett. 2018;419:84-95. [PMID: 29360561 DOI: 10.1016/j.canlet.2018.01.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
600 Dos Santos ES, Ramos JC, Normando AGC, Mariano FV, Paes Leme AF. Epigenetic alterations in salivary gland tumors. Oral Dis 2020;26:1610-8. [PMID: 31829479 DOI: 10.1111/odi.13253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
601 De Meyer T, Bady P, Trooskens G, Kurscheid S, Bloch J, Kros JM, Hainfellner JA, Stupp R, Delorenzi M, Hegi ME, Van Criekinge W. Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. Sci Rep 2015;5:15375. [PMID: 26482909 DOI: 10.1038/srep15375] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
602 Marchesi I, Giordano A, Bagella L. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis. Cell Cycle. 2014;13:516-527. [PMID: 24496329 DOI: 10.4161/cc.27921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
603 Sebio A, Lenz H. The Molecular Taxonomy of Colorectal Cancer: What’s New? Curr Colorectal Cancer Rep 2015;11:118-24. [DOI: 10.1007/s11888-015-0267-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
604 Pogribna M, Koonce NA, Mathew A, Word B, Patri AK, Lyn-Cook B, Hammons G. Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines. Nanotoxicology 2020;14:534-53. [PMID: 32031460 DOI: 10.1080/17435390.2020.1723730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
605 Helland Ø, Popa M, Bischof K, Gjertsen BT, McCormack E, Bjørge L. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer. PLoS One 2016;11:e0158208. [PMID: 27352023 DOI: 10.1371/journal.pone.0158208] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
606 Bishton M, Kenealy M, Johnstone R, Rasheed W, Prince HM. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents. Expert Review of Anticancer Therapy 2014;7:1439-49. [DOI: 10.1586/14737140.7.10.1439] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
607 Ueda S, Yamashita S, Watanabe SI, Wakabayashi M, Motoi N, Noguchi M, Sekine S, Sato Y, Ushijima T. Influence of degree of DNA degradation in formalin-fixed and paraffin-embedded tissue samples on accuracy of genome-wide DNA methylation analysis. Epigenomics 2021;13:565-76. [PMID: 33820444 DOI: 10.2217/epi-2020-0431] [Reference Citation Analysis]
608 Wang X, Prins BP, Sõber S, Laan M, Snieder H. Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension. Curr Hypertens Rep 2011;13:442-51. [PMID: 21953487 DOI: 10.1007/s11906-011-0230-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
609 Akhtar S, Hourani S, Therachiyil L, Al-Dhfyan A, Agouni A, Zeidan A, Uddin S, Korashy HM. Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway. Semin Cancer Biol 2020:S1044-579X(20)30184-X. [PMID: 32877761 DOI: 10.1016/j.semcancer.2020.08.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
610 Wang GL, Zhou LY, Luo HQ, Li NB. Electrochemical strategy for sensing DNA methylation and DNA methyltransferase activity. Analytica Chimica Acta 2013;768:76-81. [DOI: 10.1016/j.aca.2013.01.026] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
611 Tanabe A, Konno J, Tanikawa K, Sahara H. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene. Gene. 2014;535:24-32. [PMID: 24269672 DOI: 10.1016/j.gene.2013.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
612 Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell. 2008;13:69-80. [PMID: 18167341 DOI: 10.1016/j.ccr.2007.12.005] [Cited by in Crossref: 312] [Cited by in F6Publishing: 292] [Article Influence: 22.3] [Reference Citation Analysis]
613 Liu X, Tang H, Wang Z, Huang C, Zhang Z, She X, Wu M, Li G. F10 gene hypomethylation, a putative biomarker for glioma prognosis. J Neurooncol 2012;107:479-85. [PMID: 22160665 DOI: 10.1007/s11060-011-0775-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
614 Gargalionis AN, Piperi C, Adamopoulos C, Papavassiliou AG. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol 2012;44:1276-89. [PMID: 22583735 DOI: 10.1016/j.biocel.2012.05.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
615 Venza I, Visalli M, Tripodo B, De Grazia G, Loddo S, Teti D, Venza M. FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma. Br J Dermatol 2010;162:1093-7. [PMID: 19845668 DOI: 10.1111/j.1365-2133.2009.09560.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
616 Kox M, Pickkers P. Poison to the heart. Crit Care Med 2010;38:331-2. [PMID: 20023489 DOI: 10.1097/CCM.0b013e3181b7838a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
617 Fabiani E, Leone G, Giachelia M, D'alo' F, Greco M, Criscuolo M, Guidi F, Rutella S, Hohaus S, Voso MT. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leuk Lymphoma 2010;51:2275-84. [PMID: 21077739 DOI: 10.3109/10428194.2010.528093] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
618 Nagpal G, Sharma M, Kumar S, Chaudhary K, Gupta S, Gautam A, Raghava GP. PCMdb: pancreatic cancer methylation database. Sci Rep. 2014;4:4197. [PMID: 24569397 DOI: 10.1038/srep04197] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
619 Yoshida T, Kato J, Maekita T, Yamashita S, Enomoto S, Ando T, Niwa T, Deguchi H, Ueda K, Inoue I. Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric Cancer. 2013;16:488-497. [PMID: 23292007 DOI: 10.1007/s10120-012-0230-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
620 Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene. 2012;31:342-351. [PMID: 21685942 DOI: 10.1038/onc.2011.241] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
621 Zhou X, Yang XY, Popescu NC. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. Biochem Biophys Res Commun 2012;420:325-30. [PMID: 22425986 DOI: 10.1016/j.bbrc.2012.02.158] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
622 Li HT, Duymich CE, Weisenberger DJ, Liang G. Genetic and Epigenetic Alterations in Bladder Cancer. Int Neurourol J 2016;20:S84-94. [PMID: 27915480 DOI: 10.5213/inj.1632752.376] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
623 Minarovits J, Demcsák A, Banati F, Niller HH. Epigenetic Dysregulation in Virus-Associated Neoplasms. In: Minarovits J, Niller HH, editors. Patho-Epigenetics of Infectious Disease. Cham: Springer International Publishing; 2016. pp. 71-90. [DOI: 10.1007/978-3-319-24738-0_4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
624 Kelly T, Jones P. DAMD to epigenetic silence. Proc Natl Acad Sci U S A 2010;107:3-4. [PMID: 20080796 DOI: 10.1073/pnas.0913289107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
625 Rahat B, Sharma R, Bagga R, Hamid A, Kaur J. Imbalance between matrix metalloproteinases and their tissue inhibitors in preeclampsia and gestational trophoblastic diseases. Reproduction 2016;152:11-22. [PMID: 27256632 DOI: 10.1530/REP-16-0060] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 6.4] [Reference Citation Analysis]
626 Balch C, Nephew KP, Huang TH, Bapat SA. Epigenetic “bivalently marked” process of cancer stem cell-driven tumorigenesis. Bioessays 2007;29:842-5. [DOI: 10.1002/bies.20619] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
627 Husni RE, Shiba-Ishii A, Iiyama S, Shiozawa T, Kim Y, Nakagawa T, Sato T, Kano J, Minami Y, Noguchi M. DNMT3a expression pattern and its prognostic value in lung adenocarcinoma. Lung Cancer 2016;97:59-65. [PMID: 27237029 DOI: 10.1016/j.lungcan.2016.04.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
628 Nishioka C, Ikezoe T, Yang J, Nobumoto A, Tsuda M, Yokoyama A. Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci 2014;105:297-307. [PMID: 24350829 DOI: 10.1111/cas.12339] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
629 Bowden SA, Rodger EJ, Chatterjee A, Eccles MR, Stayner C. Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease. IJMS 2021;22:13327. [DOI: 10.3390/ijms222413327] [Reference Citation Analysis]
630 Wong E, Wei CL. Genome-wide distribution of DNA methylation at single-nucleotide resolution. Prog Mol Biol Transl Sci 2011;101:459-77. [PMID: 21507362 DOI: 10.1016/B978-0-12-387685-0.00015-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
631 Lu H, Yang X, Zhang Y, Lu R, Wang X. Epigenetic disorder may cause downregulation of HOXA10 in the eutopic endometrium of fertile women with endometriosis. Reprod Sci 2013;20:78-84. [PMID: 22915150 DOI: 10.1177/1933719112451146] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
632 Zhao C, Yin P, Mei C, Li N, Yao W, Li X, Qi J, Fan K, Li Z, Wang L, Shi Y, Qiu S, Fan J, Zha X. Down-regulation of DNA methyltransferase 3B in staurosporine-induced apoptosis and its mechanism in human hepatocarcinoma cell lines. Mol Cell Biochem 2013;376:111-9. [PMID: 23397112 DOI: 10.1007/s11010-012-1556-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
633 Sassa M, Hayashi Y, Watanabe R, Kikumori T, Imai T, Kurebayashi J, Kiuchi T, Murata Y. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer. Thyroid 2011;21:511-7. [PMID: 21449767 DOI: 10.1089/thy.2010.0295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
634 Su LJ. Diet, epigenetics, and cancer. Methods Mol Biol. 2012;863:377-393. [PMID: 22359307 DOI: 10.1007/978-1-61779-612-8_24] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
635 Deb M, Sengupta D, Kar S, Rath SK, Roy S, Das G, Patra SK. Epigenetic drift towards histone modifications regulates CAV1 gene expression in colon cancer. Gene 2016;581:75-84. [DOI: 10.1016/j.gene.2016.01.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
636 Li G, Yang L, Yuan Y, Zou J, Cao Y, Yang S, Xiang R, Xiang M. Virtual screening in small molecule discovery for epigenetic targets. Methods 2015;71:158-66. [DOI: 10.1016/j.ymeth.2014.11.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
637 Iioka H, Doerner SK, Tamai K. Kaiso is a bimodal modulator for Wnt/beta-catenin signaling. FEBS Lett 2009;583:627-32. [PMID: 19166851 DOI: 10.1016/j.febslet.2009.01.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
638 Mairs RJ, Boyd M. Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors. Semin Nucl Med 2011;41:334-44. [PMID: 21803183 DOI: 10.1053/j.semnuclmed.2011.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
639 Yasunaga M, Matsumura Y. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. Sci Rep. 2014;4:4852. [PMID: 24781822 DOI: 10.1038/srep04852] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
640 Garcia-Manero G. Demethylating agents in myeloid malignancies. Curr Opin Oncol 2008;20:705-10. [PMID: 18841054 DOI: 10.1097/CCO.0b013e328313699c] [Cited by in Crossref: 77] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
641 Luo CL, Xu ZG, Chen H, Ji J, Wang YH, Hu W, Wang K, Zhang WW, Yuan CH, Wang FB. LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis. Cancer Manag Res 2018;10:1449-59. [PMID: 29922089 DOI: 10.2147/CMAR.S164227] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
642 Lian B, Li H, Liu Y, Chai D, Gao Y, Zhang Y, Zhou J, Li J. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer. Breast Cancer 2021;28:448-58. [PMID: 33108608 DOI: 10.1007/s12282-020-01179-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
643 Akone SH, Ntie-Kang F, Stuhldreier F, Ewonkem MB, Noah AM, Mouelle SEM, Müller R. Natural Products Impacting DNA Methyltransferases and Histone Deacetylases. Front Pharmacol 2020;11:992. [PMID: 32903500 DOI: 10.3389/fphar.2020.00992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
644 Singh A, Gupta S, Sachan M. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives. Front Cell Dev Biol 2019;7:182. [PMID: 31608277 DOI: 10.3389/fcell.2019.00182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
645 Toyota M, Yamamoto E. DNA Methylation Changes in Cancer. Modifications of Nuclear DNA and its Regulatory Proteins. Elsevier; 2011. pp. 447-57. [DOI: 10.1016/b978-0-12-387685-0.00014-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
646 Delaney C, Garg SK, Yung R. Analysis of DNA Methylation by Pyrosequencing. Methods Mol Biol 2015;1343:249-64. [PMID: 26420722 DOI: 10.1007/978-1-4939-2963-4_19] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
647 Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Science 2010;101:36-45. [DOI: 10.1111/j.1349-7006.2009.01383.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 7.2] [Reference Citation Analysis]
648 Zhang J, Ding T, Zhang H. Insight Into Chromatin-Enriched RNA: A Key Chromatin Regulator in Tumors. Front Cell Dev Biol 2021;9:649605. [PMID: 33937246 DOI: 10.3389/fcell.2021.649605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
649 Kim J, Gao L, Tan K. Multi-analyte network markers for tumor prognosis. PLoS One 2012;7:e52973. [PMID: 23300836 DOI: 10.1371/journal.pone.0052973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
650 Seeliger B, Wilop S, Osieka R, Galm O, Jost E. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk Lymphoma 2009;50:419-26. [PMID: 19347729 DOI: 10.1080/10428190902756594] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
651 Wu M, Chen Y, Feng L, Dai H, Fang S, Xu J. MiR-206 promotes extracellular matrix accumulation and relieves infantile hemangioma through targeted inhibition of DNMT3A. Cell Cycle 2021;20:978-92. [PMID: 33945391 DOI: 10.1080/15384101.2021.1919820] [Reference Citation Analysis]
652 He X, Chang S, Zhang J, Zhao Q, Xiang H, Kusonmano K, Yang L, Sun ZS, Yang H, Wang J. MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res 2008;36:D836-41. [PMID: 17890243 DOI: 10.1093/nar/gkm730] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
653 Zhang Y, Fan J, Fan Y, Li L, He X, Xiang Q, Mu J, Zhou D, Sun X, Yang Y, Ren G, Tao Q, Xiang T. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clin Epigenetics 2018;10:26. [PMID: 30359298 DOI: 10.1186/s13148-018-0459-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
654 Daver N, Verstovsek S. Ruxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis. Leuk Lymphoma 2015;56:279-80. [PMID: 24913500 DOI: 10.3109/10428194.2014.931955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
655 Singer M, Boffelli D, Dhahbi J, Schönhuth A, Schroth GP, Martin DI, Pachter L. MetMap enables genome-scale Methyltyping for determining methylation states in populations. PLoS Comput Biol 2010;6:e1000888. [PMID: 20856582 DOI: 10.1371/journal.pcbi.1000888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
656 Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, Tan J, Cao Y, Tsao SW, Srivastava G, Chan AT, Tao Q. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas. Oncogene 2012;31:3901-12. [PMID: 22139084 DOI: 10.1038/onc.2011.541] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
657 Giudice FS, Pinto DS Jr, Nör JE, Squarize CH, Castilho RM. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLoS One 2013;8:e58672. [PMID: 23527004 DOI: 10.1371/journal.pone.0058672] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
658 Li N, Sutarlie L, Lew QJ, Chao SH, Su X. Identification of lysine K18 acetylation on histone H3 peptide using gold nanoparticles' aggregation behaviour. Amino Acids 2016;48:1023-31. [PMID: 26718709 DOI: 10.1007/s00726-015-2148-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
659 Zhang LT, Zhang LJ, Zhang JJ, Ye XX, Xie AM, Chen LY, Kang JX, Cai C. Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line. Bioanalysis. 2013;5:839-845. [PMID: 23534428 DOI: 10.4155/bio.13.28] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
660 Koturbash I, Scherhag A, Sorrentino J, Sexton K, Bodnar W, Swenberg JA, Beland FA, Pardo-Manuel Devillena F, Rusyn I, Pogribny IP. Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene. Toxicol Sci 2011;122:448-56. [PMID: 21602187 DOI: 10.1093/toxsci/kfr133] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
661 Li H, Niederkorn JY, Sadegh L, Mellon J, Chen PW. Epigenetic regulation of CXCR4 expression by the ocular microenvironment. Invest Ophthalmol Vis Sci 2013;54:234-43. [PMID: 23188729 DOI: 10.1167/iovs.12-10643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
662 Plourde KV, Labrie Y, Ouellette G, Pouliot M, Durocher F. Genome-wide methylation analysis of DNMT3B gene isoforms revealed specific methylation profiles in breast cell lines. Epigenomics 2016;8:1209-26. [DOI: 10.2217/epi-2016-0013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
663 Wu J, Hu CP, Gu QH, Li YP, Song M. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. Acta Pharmacol Sin 2010;31:93-101. [PMID: 20048748 DOI: 10.1038/aps.2009.183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
664 Lichtenstein AV. Carcinogenesis: Evolution of concepts. Biochemistry Moscow 2009;74:353-61. [DOI: 10.1134/s0006297909040014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
665 Snellenberg S, Cillessen SA, Van Criekinge W, Bosch L, Meijer CJ, Snijders PJ, Steenbergen RD. Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers. Carcinogenesis 2014;35:2611-8. [PMID: 25233927 DOI: 10.1093/carcin/bgu197] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
666 Dai QX, Liao YH, Deng XH, Xiao XL, Zhang L, Zhou L. A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer. Clin Chim Acta 2020;508:54-60. [PMID: 32423860 DOI: 10.1016/j.cca.2020.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
667 Deatherage DE, Potter D, Yan PS, Huang TH, Lin S. Methylation analysis by microarray. Methods Mol Biol 2009;556:117-39. [PMID: 19488875 DOI: 10.1007/978-1-60327-192-9_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
668 Hagemann S, Heil O, Lyko F, Brueckner B. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One 2011;6:e17388. [PMID: 21408221 DOI: 10.1371/journal.pone.0017388] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 8.5] [Reference Citation Analysis]
669 Gerges S, Rohde K, Fulda S. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells. Cancer Letters 2016;375:127-32. [DOI: 10.1016/j.canlet.2016.02.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
670 Kilin V, Gavvala K, Barthes NP, Michel BY, Shin D, Boudier C, Mauffret O, Yashchuk V, Mousli M, Ruff M, Granger F, Eiler S, Bronner C, Tor Y, Burger A, Mély Y. Dynamics of Methylated Cytosine Flipping by UHRF1. J Am Chem Soc 2017;139:2520-8. [PMID: 28112929 DOI: 10.1021/jacs.7b00154] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
671 Atschekzei F, Hennenlotter J, Jänisch S, Großhennig A, Tränkenschuh W, Waalkes S, Peters I, Dörk T, Merseburger AS, Stenzl A, Kuczyk MA, Serth J. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence. Epigenetics 2012;7:447-57. [PMID: 22419128 DOI: 10.4161/epi.19614] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
672 Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumour Biol 2012;33:277-85. [PMID: 22219034 DOI: 10.1007/s13277-011-0308-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
673 Maegawa S, Hinkal G, Kim HS, Shen L, Zhang L, Zhang J, Zhang N, Liang S, Donehower LA, Issa JP. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 2010;20:332-40. [PMID: 20107151 DOI: 10.1101/gr.096826.109] [Cited by in Crossref: 350] [Cited by in F6Publishing: 317] [Article Influence: 29.2] [Reference Citation Analysis]
674 Tapia-Vieyra JV, Delgado-Coello B, Mas-Oliva J. Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications. Arch Med Res 2017;48:12-26. [PMID: 28577865 DOI: 10.1016/j.arcmed.2017.03.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
675 Guo H, Zhang B, Nairn AV, Nagy T, Moremen KW, Buckhaults P, Pierce M. O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1. J Biol Chem. 2017;292:4123-4137. [PMID: 28096468 DOI: 10.1074/jbc.m116.763201] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
676 Eze OP, Starker LF, Carling T. The role of epigenetic alterations in papillary thyroid carcinogenesis. J Thyroid Res 2011;2011:895470. [PMID: 21765995 DOI: 10.4061/2011/895470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
677 Enninga EA, Nevala WK, Holtan SG, Markovic SN. Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics. Front Immunol 2015;6:424. [PMID: 26379664 DOI: 10.3389/fimmu.2015.00424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
678 Bai H, Cao D, Yang J, Li M, Zhang Z, Shen K. Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy. J Cell Mol Med 2016;20:581-93. [PMID: 26800494 DOI: 10.1111/jcmm.12771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
679 Parmigiani G, Boca S, Lin J, Kinzler KW, Velculescu V, Vogelstein B. Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics 2009;93:17-21. [PMID: 18692126 DOI: 10.1016/j.ygeno.2008.07.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
680 Xu J, Wang YY, Dai YJ, Zhang W, Zhang WN, Xiong SM, Gu ZH, Wang KK, Zeng R, Chen Z, Chen SJ. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proc Natl Acad Sci U S A 2014;111:2620-5. [PMID: 24497509 DOI: 10.1073/pnas.1400150111] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
681 Verma M. The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools. Adv Exp Med Biol 2015;867:59-80. [PMID: 26530360 DOI: 10.1007/978-94-017-7215-0_5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
682 Ryazansky SS, Gvozdev VA. Small RNAs and cancerogenesis. Biochemistry Moscow 2008;73:514-27. [DOI: 10.1134/s0006297908050040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
683 Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW, Zuo T, Rodriguez B, Lin CH, Cheng AL, Huang TH. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol 2010;248:111-21. [PMID: 20678512 DOI: 10.1016/j.taap.2010.07.014] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 7.0] [Reference Citation Analysis]
684 Barzily-Rokni M, Friedman N, Ron-Bigger S, Isaac S, Michlin D, Eden A. Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A). Nucleic Acids Res. 2011;39:1326-1335. [PMID: 21030442 DOI: 10.1093/nar/gkq994] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
685 Hashimoto S, Qu W, Ahsan B, Ogoshi K, Sasaki A, Nakatani Y, Lee Y, Ogawa M, Ametani A, Suzuki Y, Sugano S, Lee CC, Nutter RC, Morishita S, Matsushima K. High-resolution analysis of the 5'-end transcriptome using a next generation DNA sequencer. PLoS One 2009;4:e4108. [PMID: 19119315 DOI: 10.1371/journal.pone.0004108] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6